Document:

<PAGE>
                                                                EXHIBIT 10.8

                            STOCK PURCHASE AGREEMENT

                                  BY AND AMONG

                         MERCER MUTUAL INSURANCE COMPANY

                                       AND

                                H. THOMAS DAVIS,

                                       AND

                         FRANKLIN HOLDING COMPANY, INC.

                            DATED AS OF APRIL 6, 2001

<PAGE>

         EXHIBITS

EXHIBIT A - FHI Shareholder Agreement among Mercer Mutual Insurance Company, H.
Thomas Davis and FHI

EXHIBIT B - Agency Business Agreement between Mercer Mutual Insurance Company
and H. Thomas Davis

EXHIBIT C - Employment Agreement between Mercer Mutual Insurance Company and H.
Thomas Davis

EXHIBIT D - Third Amended and Restated Certificate of Incorporation of FHI.

<PAGE>

                            STOCK PURCHASE AGREEMENT

         This STOCK PURCHASE AGREEMENT(this "Agreement") is made and entered
into as of March __, 2001, by and among MERCER MUTUAL INSURANCE COMPANY, a
Pennsylvania corporation ("Buyer"), H. THOMAS DAVIS ("Davis"), and FRANKLIN
HOLDING COMPANY, INC., a Delaware corporation ("FHI"). Buyer, Davis, and FHI are
sometimes collectively referred to herein as the "Parties" and individually as a
"Party."

                                    RECITALS

         Davis owns (i) 210,000 shares of FHI Class A Voting Common Stock (the
"Class A Stock"), and (ii) and options to acquire 590,000 shares of Class A
Stock (the "Options").

         On or prior to the date of closing contemplated hereunder, Davis will
exchange the options to acquire 590,000 shares of Class A Stock for options (as
so exchanged, the "Options") to acquire 590,000 shares of Class B Non-Voting
Common Stock (the "Class B Stock")

         Anthony Robert Scatena, Raymond Edward Nestlerode, Sr., Raymond Edward
Nestlerode, Jr., Joseph Russell Nestlerode, Sr., William J. Edwards, Michael
Peter Nestarick (the "Series A Holders" and, together with Davis, the "Selling
Shareholders") own 10,000 shares of FHI Series A Convertible Redeemable
Preferred Stock (the "Series A Preferred Stock").

         Davis has agreed to sell to Buyer, and Buyer has agreed to purchase
from Davis, 102,900 shares of Class A Stock and Options to acquire 295,000
shares of Class B Stock.

         The Series A Holders have agreed to sell to the Buyer, and the Buyer
has agreed to purchase from the Series A Holders, 5000 shares of Series A
Preferred Stock.

         NOW, THEREFORE, in consideration of the covenants and representations
set forth herein, and for other good and valuable consideration, the Parties
agree as follows:

                                   ARTICLE I -

                                   DEFINITIONS

                                       1

<PAGE>

                  1.1      Construction. References to any federal, state, local
or foreign statute or law shall be deemed also to refer to all rules and
regulations promulgated thereunder, unless the context requires otherwise.
Unless the context otherwise requires, all references to "Sections," "Exhibits"
and "Schedules" shall be deemed to refer to Sections within or Exhibits and
Schedules to this Agreement. All Exhibits and Schedules to this Agreement are
hereby incorporated herein. The word "including" shall mean including without
limitation. Unless the context otherwise requires, any word used in the singular
form shall be interpreted as including the plural form thereof, and vice versa,
and any word used in one gender shall be interpreted as including the other
gender, as necessary or appropriate. Any reference to facts or information
"known" to a Party, or words having similar meaning, shall refer to the
conscious awareness of information of the directors and those responsible
officers and employees of such Party and its Subsidiaries charged with
administrative or operational responsibility for such matters, and which is
known or would be known to any one or more of them following reasonable
investigation under the circumstances.

                  1.2      Definitions. Certain capitalized terms used in this
Agreement shall have the meanings ascribed to such terms in this Section 1.2,
unless the context clearly requires otherwise.

                           (a)      "Bank Pledge" shall have the meaning set
forth in Section 2.2.

                           (b)      "Buyer" shall mean Mercer Mutual Insurance
Company, an Pennsylvania corporation.

                           (c)      "Affiliate" shall have the meaning set forth
in Section 12b-2 of the Exchange Act.

                           (d)      "Agreement" shall mean this Stock Purchase
Agreement.

                           (e)      "Annual Statements" shall have the meaning
set forth in Section 3.9(a).

                           (f)      "Antitrust Laws" shall have the meaning set
forth in Section 6.6(b).

                           (g)      "Certificate of Incorporation" shall have
the meaning set forth in Section 3.1.

                           (h)      "Bylaws" shall have the meaning set forth in
Section 3.1.

                                       2

<PAGE>

                           (i)      "CERCLA" means the Comprehensive
Environmental Response, Compensation and Liability Act, as amended.

                           (j)      "Class A Stock" means the Class A Voting
Common Stock, $0.10 par value per share, of FHI.

                           (k)      "Class B Stock" means the Class B Non-Voting
Stock, $0.10 par value per share, of FHI.

                           (l)      "Closing" shall have the meaning set forth
in Section 2.4.

                           (m)      "Closing Date" shall have the meaning set
forth in Section 2.4.

                           (n)      "COBRA" means the federal Consolidated
Omnibus Budget Reconciliation Act of 1985, as amended.

                           (o)      "Code" means the Internal Revenue Code of
1986, as amended.

                           (p)      "Confidential Information" shall have the
meaning set forth in Section 3.11(g).

                           (q)      "Contract" or "Contracts" means any
mortgage, indenture, lease, note, contract or other agreement or instrument to
which a Person is a party or by which such Person or such Person's assets are or
may be bound.

                           (r)      "Data Processing Systems" shall have the
meaning set forth in Section 3.34(b).

                           (s)      "Davis" means H. Thomas Davis, an
individual, and his heirs, personal representatives and assigns.

                           (t)      "Effective Time" shall have the meaning set
forth in Section 2.4.

                           (u)      "Environmental and Safety Laws" shall mean
any federal, state or local laws, ordinances, codes, regulations, rules,
policies and orders that are intended to assure the protection of the
environment, or that classify, regulate, call for the remediation of, require
reporting with respect to, or list or define air, water, groundwater, solid
waste, hazardous or toxic substances, materials, wastes, pollutants or
contaminants, or which are intended to assure the safety of employees, workers
or other Persons, including the public.

                                       3

<PAGE>

                           (v)      "ERISA" means the Employee Retirement Income
Security Act of 1974, as amended, as set forth in Section 3.14(a).

                           (w)      "ERISA Affiliate" shall have the meaning set
forth in Section 3.14(c)(vii).

                           (x)      "Exchange Act" means the Securities Exchange
Act of 1934, as amended, as set forth in Section 3.4.

                           (y)      "Facilities" shall mean all buildings and
improvements on the Property of FHI or its Subsidiaries.

                           (z)      "FHI" shall mean Franklin Holding Company,
Inc., a Delaware corporation.

                           (aa)     FHI Authorizations" shall have the meaning
set forth in Section 3.9(c).

                           (bb)     "FHI Balance Sheet Date" shall mean December
31, 2000.

                           (cc)     "FHI Balance Sheet" shall mean the balance
sheet of FHI as of the FHI Balance Sheet Date.

                           (dd)     "FHI Capital Stock" means the Class A Stock,
the Class B Stock, the Series A Preferred Stock and the Series B Preferred
Stock.

                           (ee)     "FHI Disclosure Schedule" shall have the
meaning set forth in the first paragraph of Article III.

                           (ff)     "FHI Employee Plans" shall have the meaning
set forth in Section 3.14(a).

                           (gg)     "FHI Financial Statements" shall have the
meaning set forth in Section 3.4.

                           (hh)     "Fraudulent Breach" means a statement
contained in Article III (other than Section 3.30) or in a Schedule annexed
hereto, of the existence or absence of a material fact or circumstance, which
statement was one that the Buyer had no basis to believe was false at the time
of Closing, that is held by a final, non-appealable order of a court of
competent jurisdiction to have been a willful, intentional and knowing (as
opposed to negligent) statement made with specific intent to defraud.

                                       4

<PAGE>

                           (ii)     "GAAP" means Unites States Generally
Accepted Accounting Principles.

                           (jj)     "Governmental Entity" means any court,
administrative agency or commission or other governmental or regulatory agency,
authority or instrumentality of any federal, state, local or foreign government,
of any kind, type or nature.

                           (kk)     "Hazardous Materials" shall mean any toxic
or hazardous substance, material or waste or any pollutant or contaminant, or
infectious or radioactive substance or material, including without limitation,
those substances, materials and wastes defined in or regulated under any
Environmental and Safety Laws.

                           (ll)     "Indemnifiable Claims" shall have the
meaning set forth in Section 9.1

                           (mm)     "Insurance Authorities" shall have the
meaning set forth in Section 3.9(a).

                           (nn)     "Insurance Licenses" shall have the meaning
set forth in Section 3.9(a).

                           (oo)     "Insurance Reports" shall have the meaning
set forth in Section 3.9(a).

                           (pp)     "Intellectual Property" shall have the
meaning set forth in Section 3.11(a).

                           (qq)     "Liens" shall have the meaning set forth in
Section 3.1.

                           (rr)     "Material Adverse Effect" with respect to
any Person means any event, change, condition or effect, that (i) has, or could
reasonably be expected to have, a materially adverse effect on the condition
(financial or otherwise), properties, assets, liabilities, business, operations
or results of operations of such Person and its Subsidiaries, taken as a whole
(whether or not arising from transactions in the ordinary course of business)
(excluding changes in investment portfolio values due to changes in interest
rates or changes in SAAP or GAAP that affect the insurance industry as a whole),
(ii) materially impairs, or could reasonably be expected to materially impair,
the ability of such Person to perform its obligations under this Agreement or
any related agreement or to consummate the transactions contemplated by this
Agreement, or (iii) causes A. M. Best, either orally or in writing, to advise
such Person that it's A. M. Best rating will be, or is likely to be, reduced.

                                       5

<PAGE>

                           (ss)     "Options" means the options to acquire
590,000 shares of Class B Stock.

                           (tt)     "Order" shall have the meaning set forth in
Section 6.6(b).

                           (uu)     "Parties" shall mean Buyer, Davis and FHI,
collectively.

                           (vv)     Party" shall mean Buyer, Davis or FHI,
individually.

                           (ww)     "Person" means any natural person or
individual, trustee, corporation, general or limited partnership, limited
liability company or partnership, joint venture, joint stock company, bank,
firm, Governmental Entity, trust, association, organization or unincorporated
entity of any kind.

                           (xx)     "Property" shall mean all real property
leased or owned by FHI or its Subsidiaries either currently or in the past.

                           (yy)     "Quarterly Statements" shall have the
meaning set forth in Section 3.9(a).

                           (zz)     "SAAP" shall mean the statutory accounting
principles required by the Pennsylvania Department of Insurance.

                           (aaa)    "Schedule" shall refer to an applicable
portion of the FHI Disclosure Schedule.

                           (bbb)    "Series A Holders" means Anthony Robert
Scatena, Raymond Edward Nestlerode, Sr., Raymond Edward Nestlerode, Jr., Joseph
Russell, William J. Edwards, Michael Peter Nestarick and their respective heirs,
personal representatives and assigns.

                           (ccc)    "Series A Preferred Stock" means the Series
A Convertible Redeemable Preferred Stock, $100 par value per share, of FHI.

                           (ddd)    "Series A Stock Purchase Agreement" means
the Stock Purchase Agreement dated on or about the date hereof among Buyer and
the Series A Holders pursuant to which Buyer will acquire 5000 shares of Series
A Preferred Stock.

                           (eee)    "Series B Preferred Stock" means the Series
B Cumulative Redeemable Preferred Stock, $100 par value per share, of FHI.

                           (fff)    "Series B Holder" means the holder of Series
B Preferred Stock.

                                        6

<PAGE>

                           (ggg)    "Selling Shareholders" means Davis and the
Series A Holders.

                           (hhh)    "Shareholder Documents" means the following
documents and instruments, copies of which have been furnished to the Buyer:
Certificate of Incorporation and By-laws of FHI, the Subscription and
Shareholders Agreement among Davis, FHI and the Series A Holders, the Securities
Purchase Agreement between FHI and the Series B Holder, the Class B Non-voting
Common stock Purchase Warrant issued by FHI to the Series B Holder, and the
Internal Shareholders Agreement between Davis and the Series B Holder.

                           (iii)    "Subsidiary" or "Subsidiaries" shall mean,
with respect to any Party (other than Davis), any corporation, limited liability
company, partnership, trust, limited partnership, joint venture, or other
business association or entity, at least a majority of the voting securities or
economic interests of which is directly or indirectly owned or controlled by
such Party or by any one or more of its Subsidiaries.

                           (jjj)    "Superior Proposal" shall have the meaning
set forth in Section 5.3.

                           (kkk)    "Takeover Proposal" shall have the meaning
set forth in Section 8.3(f).

                           (lll)    "Tax Authority" means any Governmental
Entity responsible for the imposition or collection of any Tax or with whom any
Tax Return is required to be filed.

                           (mmm)    "Tax Return" shall mean any return,
statement, report or form (including estimated Tax returns and reports,
withholding Tax returns and reports and information reports and returns)
required to be filed with respect to Taxes.

                           (nnn)    "Tax" (and, with correlative meaning,
"Taxes" and "Taxable") means (i) any net income, alternative or add-on minimum
tax, gross income, gross receipts, premium, sales, use, ad valorem, transfer,
franchise, profits, license, withholding, payroll, employment, excise,
severance, stamp, occupation, premium, property, environmental or windfall
profit tax, custom, duty or other tax, governmental fee or other like assessment
or charge of any kind whatsoever, together with any interest or any penalty,
addition to tax or additional amount imposed by any Tax Authority, (ii) any
liability for the payment of any amounts of the type described in (i) as a
result of being a member of an affiliated, consolidated, combined or unitary
group for any Taxable period and (iii) any

                                       7

<PAGE>

liability for the payment of any amounts of the type described in (i) or (ii) as
a result of any express or implied obligation to indemnify any other Person.

                           (ooo)    "Third Party Intellectual Property Rights"
shall mean all licenses, sublicenses and other Contracts as to which FHI or any
of its Subsidiaries is a party and pursuant to which FHI or any of its
Subsidiaries is authorized to use any third party patents, trademarks,
copyrights, trade secrets or other proprietary right, including software used in
the business of FHI or any of its Subsidiaries or are incorporated in, are, or
form a part of any of FHI'S or any of its Subsidiaries' products or services.

                           (ppp)    "Treasury Regulations" shall mean
regulations adopted by the Internal Revenue Service pursuant to the Code.

                                  ARTICLE II -

                           PURCHASE AND SALE OF STOCK

                  2.1      Purchase and Sale of Class A Stock. Subject to the
terms and conditions of this Agreement, on the Closing Date, Davis shall sell to
Buyer, and Buyer shall purchase from Davis, 102,900 shares of Class A Stock. The
purchase price for the share of Class A Stock shall be $2,475,000

                  2.2      Purchase and Sale of Options. Subject to the terms
and conditions of this Agreement, on the Closing Date, Davis shall sell to
Buyer, and Buyer shall purchase from Davis, Options to acquire 295,000 shares of
Class B Stock. The purchase price for the Options shall be $25,000.

                  2.3      Payment. The purchase price for the shares and the
options shall be paid by wire transfer at Closing to a bank account designated
by Davis, less the amount required to be remitted by transfer at Closing to
Jersey Shore State Bank in order to effect the termination of the collateral
pledge held by the bank against the shares ("Bank Pledge"). Prior to Closing,
Davis shall furnish to Buyer a payoff letter issued by the bank setting forth an
amount (less than the purchase price) to be paid to the bank at Closing to cause
the complete termination of the Bank Pledge.

                  2.4      Closing; Closing Date. The closing ("Closing") shall
take place at the offices of Stevens & Lee, 208 North Third Street, Harrisburg,
Pennsylvania at 10:00 A.M., on the date (the "Closing Date") that is five (5)
days after the satisfaction of all conditions to closing (other than
satisfaction of conditions to closing that can only be satisfied at closing) or
at such time and date thereafter as the Parties may mutually agree (the
"Effective Time").

                                       8

<PAGE>

                  2.5      Closing Deliveries.

                           (a)      By Davis. At the Closing, Davis shall
deliver, or cause to be delivered,

                                    (i)      a share certificate to the Buyer
         for 102,900 Shares of Class A Stock;

                                    (ii)     an assignment to the Buyer of the
         Options to acquire 295,000 shares of Class B Stock; and

                                    (iii)    all other documents and items
         required to be delivered by Davis pursuant to Section 7.3.

                           (b)      By Buyer. At the Closing, Buyer shall
deliver, or cause to be delivered,

                                    (i)      wire transfers of immediately
         available funds in accordance with Section 2.3 hereof; and

                                    (ii)     all other documents and items
         required to be delivered pursuant to Section 7.2 hereof.

                                  ARTICLE III -

                 REPRESENTATIONS AND WARRANTIES OF DAVIS AND FHI

         Davis and FHI represent and warrant to Buyer that the statements in
this Article III are true and correct, except as set forth in the disclosure
schedule delivered by FHI to Buyer as of this date and acknowledged by the
Parties (the "FHI Disclosure Schedule"). The mere listing (or inclusion of a
copy) of a document or other item shall not be deemed adequate to disclose an
exception to a representation or warranty made herein (unless the
representation or warranty has to do with the existence of the document or
other item itself).  The FHI Disclosure Schedule is arranged in paragraphs
corresponding to the lettered and numbered sections and schedules contained in
or referred to in this Article III. The representations and warranties of Davis
and FHI contained in this Article III and elsewhere in this Agreement, or in
the FHI Disclosure Schedule or any other document delivered pursuant to or
contemplated by this Agreement, shall not be affected or deemed waived by
reason of the fact that Buyer and/or its representatives knew or should have
known that any such representation or warranty is or might be untrue or
inaccurate in any respect. For purposes of the representations and warranties
of Davis and FHI contained in this Article III and elsewhere in this Agreement,
or in the FHI Disclosure Schedule or any other

                                       9

<PAGE>

document delivered pursuant to or contemplated by this Agreement, the
assumption has been made that the conditions set forth in subsections 7.1(b)
and (g) will be satisfied and that the Bank Pledge will be discharged in
accordance with Section 2.3 hereof.

                  3.1      Organization, Standing and Power. FHI and each of
FHI's Subsidiaries is a corporation duly organized, validly existing and in good
standing under the laws of its jurisdiction of organization, has all requisite
corporate power and authority to own properties and to carry on business as now
being conducted and as proposed to be conducted and is duly qualified to do
business and is in good standing in each jurisdiction where its ownership or
leasing of property or the conduct of its business requires it to be so
qualified, except where the failure to be so qualified would not have a Material
Adverse Effect on FHI. Each FHI Subsidiary which is engaged in the business of
insurance has valid and subsisting licenses to conduct the insurance business
conducted by such Subsidiary. All of FHI's Subsidiaries are listed on Schedule
3.1, identifying thereon (with respect to each Subsidiary which is an insurance
company) its state of domicile and the states in which it is licensed to conduct
an insurance business. Except as disclosed on Schedule 3.1, FHI does not
directly or indirectly own any equity or similar interest in, or any interest
convertible or exchangeable or exercisable for, any equity or similar interest
constituting in excess of five percent (5%) of the ownership in, any other
corporation, partnership, joint venture or other business association or entity.
FHI has delivered to Buyer a true and correct copy of the Certificate of
Incorporation, as amended (the "Certificate of Incorporation") of FHI, and the
Bylaws, as amended (the "Bylaws") of FHI, and the Certificate of Incorporation
and Bylaws or other organizational documents, as applicable, of each of its
Subsidiaries, each as amended to date. FHI is not in violation of any of the
provisions of the Certificate of Incorporation or Bylaws, and no such Subsidiary
is in violation of any provisions of its equivalent organizational documents.
Except as set forth on Schedule 3.1, FHI owns beneficially and of record all
outstanding shares of capital stock of each of its Subsidiaries, and all such
shares of capital stock are duly authorized, validly issued, fully paid and
nonassessable. All outstanding shares of capital stock of each such Subsidiary
are owned by FHI free and clear of any charge, mortgage, pledge, security
interest, restriction, claim, lien, or encumbrance (collectively, "Liens").
Except as set forth on Schedule 3.1, there are no outstanding subscriptions,
options, warrants, puts, calls, rights, exchangeable or convertible securities,
voting agreements or proxies, or other commitments or agreements of any
character relating to the issued or unissued capital stock or other securities
of any such Subsidiary, or otherwise obligating FHI or any such Subsidiary to
issue, transfer, sell, purchase, redeem or otherwise acquire any such
securities.

                                       10

<PAGE>

                  3.2      Capital Structure. The authorized capital stock of
FHI consists of 800,000 shares of Class A Stock, 400,000 shares of Class B Stock
and 26,450 shares of preferred stock divided into 10,000 shares of Series A
Preferred Stock and 16,450 shares of Series B Preferred Stock. As of the date
hereof, 210,000 shares of Class A Stock were issued and outstanding and held by
Davis, no shares of Class B Stock were issued and outstanding, 10,000 shares of
Series A Preferred Stock were issued and outstanding and held by the Series A
Holders, and 11,753.8311 shares of Series B Preferred Stock were issued and
outstanding and held by American Reinsurance Company. No shares of FHI Capital
Stock were held in treasury. All outstanding shares of FHI Capital Stock are
duly authorized, validly issued, fully paid and nonassessable and are free and
clear of any Liens other than Liens created by or imposed upon the holders
thereof, and, except as set forth in Schedule 3.2 or in the Shareholder
Documents, are not subject to preemptive rights or rights of first refusal
created by statute, the Certificate of Incorporation or Bylaws of FHI, or any
agreement to which FHI is a party or by which it is bound. Davis holds options
to acquire 590,000 shares of Class A Stock; the Series A Holders hold options to
acquire shares of Class B Stock under certain circumstances pursuant to Section
7.4 of a Subscription and Shareholder Agreement dated July 17, 1997 by and among
Davis, FHI and the Series A Holders; and American Reinsurance Company holds a
warrant to acquire 100,000 shares of Class B Stock, subject to adjustment as set
forth in the warrant. Except as set forth in the preceding sentence or in the
Shareholder Documents, there are no other options, commitments or agreements of
any character to which FHI is a party or by which it is bound obligating FHI to
issue, deliver, sell, repurchase or redeem, or cause to be issued, delivered,
sold, repurchased or redeemed, any shares of FHI Capital Stock, or obligating
FHI to grant, extend, accelerate the vesting of, change the price of, or
otherwise amend or enter into any such option, warrant, call, right, commitment
or agreement. All issuances of securities by FHI and its Subsidiaries, including
all FHI Capital Stock, since their respective dates of incorporation complied
with all applicable federal and state securities laws, and all registrations and
filings required thereby have been timely made by or on behalf of the issuer
thereof. Except as set forth on Schedule 3.2 or in the Shareholder Documents,
there are no Contracts, commitments or understandings relating to the voting,
purchase or sale of any FHI Capital Stock or any of its Subsidiaries (i) between
or among FHI and any of its stockholders or any third party, and (ii) between or
among any of FHI's stockholders or any third party. True and complete copies of
any agreements and instruments relating to the issuance, sale, purchase or
redemption of any FHI Capital Stock, are listed on Schedule 3.2 (except that the
Shareholder Documents are hereby incorporated therein by reference) and have
been provided to Buyer.

                                       11

<PAGE>

                  3.3      Authority. FHI has all requisite corporate power and
authority, and Davis have all requisite power and authority, to enter into this
Agreement and to consummate the transactions contemplated hereby. The execution
and delivery of this Agreement and the consummation of the transactions
contemplated hereby have been duly authorized by all necessary corporate action
on the part of FHI. This Agreement has been duly executed and delivered by FHI
and Davis and constitutes a valid and binding obligation of FHI enforceable
against each of FHI and Davis in accordance with its terms, except as
enforceability may be limited by bankruptcy and other laws affecting the rights
and remedies of creditors generally and general principles of equity. Except as
described on Schedule 3.3, the execution and delivery of this Agreement by FHI
and Davis does not, and the consummation of the transactions contemplated hereby
will not, conflict with, or result in any violation of, or default under (with
or without notice or lapse of time, or both), or give rise to a right of
termination, amendment, cancellation or acceleration of any obligation or loss
of any benefit under (i) any provision of the Certificate of Incorporation or
Bylaws of FHI or equivalent organizational documents of any of FHI's
Subsidiaries, as amended, (ii) any Contract to which Davis, FHI or any of its
Subsidiaries is a party or by which any of them is bound, or (iii) any permit,
concession, franchise, license, judgment, order, decree, statute, law,
ordinance, rule or regulation applicable to Davis, FHI or any of its
Subsidiaries or any of their properties or assets, or to which Davis, FHI or any
of its Subsidiaries or any of their properties or assets is subject or bound or
that give rise to any Lien, except where such conflict, violation, default,
termination, cancellation or acceleration with respect to the foregoing
provisions of (iii) would not have had and could not reasonably be expected to
have a Material Adverse Effect. No consent, approval, order or authorization of,
or registration, declaration or filing with, any Governmental Entity is required
by or with respect to Davis, FHI or any of its Subsidiaries in connection with
the execution and delivery of this Agreement, or the consummation of the
transactions contemplated hereby, except for the approval of the Pennsylvania
Department of Insurance.

                  3.4      Financial Statements. FHI has provided to Buyer the
audited financial statements, including the footnotes thereto, of FHI and its
Subsidiaries for the fiscal year ended December 31, 2000, and the related report
of Brown Schultz Sheridan and Fritz thereon, (the "FHI Financial Statements").
The Financial Statements of FHI were prepared in accordance with GAAP applied on
a consistent basis throughout the periods presented. The FHI Financial
Statements fairly present the consolidated financial condition, operating
results, cash flows and changes in stockholders' equity of FHI and its
Subsidiaries at the dates and during the periods indicated therein (subject, in
the case of unaudited statements, to normal, recurring year-end adjustments that
were not material in amount). No

                                       12

<PAGE>

financial statements of any Person other than FHI's Subsidiaries are required by
GAAP to be included in the consolidated financial statements of FHI.

                  3.5      Absence of Certain Changes. Since the FHI Balance
Sheet Date, FHI and its Subsidiaries have conducted their business in the
ordinary course consistent with past practice and, except as set forth in
Schedule 3.5, there has not occurred: (i) any change, event or condition
(whether or not covered by insurance or reinsurance) that has resulted in, or
might reasonably be expected to result in, a Material Adverse Effect on FHI;
(ii) any acquisition, sale or transfer of any material asset of FHI or any of
its Subsidiaries other than in the ordinary course of business and consistent
with past practice; (iii) any change in accounting methods or practices
(including any change in depreciation or amortization policies or rates) by FHI
or any revaluation by FHI of any of its or any of its Subsidiaries' assets; (iv)
any declaration, setting aside, or payment of a dividend or other distribution
with respect to the shares of FHI (other than stock dividends to the Series B
Holders), or any direct or indirect redemption, purchase or other acquisition by
FHI of any FHI Capital Stock; (v) any material Contract entered into by FHI or
any of its Subsidiaries, other than in the ordinary course of business and as
provided to Buyer, or any material amendment or termination of, or default
under, any material Contract to which FHI or any of its Subsidiaries is a party
or by which it is bound; (vi) any amendment or change to the Certificate of
Incorporation or Bylaws of FHI or organizational documents of any of its
Subsidiaries; or (vii) any increase in or modification of the compensation,
benefits or severance amounts payable or to become payable by FHI or any of its
Subsidiaries to any of their directors, employees or insurance agents (other
than compensation and benefit increases made solely in the ordinary course of
business). FHI and its Subsidiaries have not agreed since the FHI Balance Sheet
Date to do any of the things described in the preceding clauses (i) through
(vii) and are not currently involved in any negotiations to do any of the things
described in the preceding clauses (i) through (vii) (other than negotiations
with Buyer and its representatives regarding the transactions contemplated by
this Agreement ).

                  3.6      Absence of Undisclosed Liabilities. FHI and its
Subsidiaries have no material obligations or liabilities of any nature (whether
known or unknown, asserted or unasserted, absolute or contingent, accrued or
unaccrued, liquidated or unliquidated, and due or to become due), other than (i)
those set forth or adequately provided for in the FHI Balance Sheet or in the
footnotes thereto (including claims reserves for reported and incurred but not
reported claims under policies of insurance issued by FHI and its Subsidiaries),
(ii) those incurred in the ordinary course of business since the FHI Balance
Sheet Date and consistent with past practice (only if such obligations or
liabilities do not arise out of, result from or relate to any breach of
contract, breach of warranty, tort, infringement or

                                       13

<PAGE>

violation of law); and (iii) those incurred in connection with the execution of
this Agreement.

                  3.7      Litigation.

                           (a)      Except as set forth on Schedule 3.7(a),
there is no private or governmental action, suit, proceeding, claim, arbitration
or investigation pending before any Governmental Entity, or to the knowledge of
FHI or any of its Subsidiaries threatened, against FHI or any of its
Subsidiaries or any of their respective properties or any of their respective
officers or directors, except for policyholder claims in the ordinary course of
business made under insurance policies issued by FHI's Subsidiaries none of
which (i) if determined adversely would have or could reasonably be expected to
have a Material Adverse Effect on FHI, net of posted reserves and reinsurance
receivables that may be recorded as an asset under GAAP, or (ii) involves claims
of bad faith, extra contractual claims, or claims giving rise to punitive
damages (in each case, excluding any and all damages based on amounts
recoverable under the terms of the applicable insurance policy). There is no
agreement, judgment, injunction, decree or order against FHI or any of its
Subsidiaries, or, to the knowledge of FHI and its Subsidiaries, any of their
respective directors, officers or stockholders, that would prevent, enjoin,
alter or materially delay any of the transactions contemplated by this
Agreement, or that has or could reasonably be expected to have a Material
Adverse Effect on FHI or its Subsidiaries. Neither FHI nor any of its
Subsidiaries has been advised by any Person that such Person is contemplating
issuing or requesting (or is considering the appropriateness of issuing or
requesting) any such agreement, judgment, injunction, decree or order.

                           (b)      Except as described on Schedule 3.7(b),
during the five year period prior to the date hereof there have been no civil,
criminal or administrative proceedings or investigations to which Davis, FHI or
any of its Subsidiaries has been a party which sought (i) payment of any
criminal or administrative fines or penalties by Davis, FHI or any of its
Subsidiaries or any employee thereof, whether in such Person's capacity as an
employee of FHI or any FHI Subsidiary or otherwise, (ii) civil damages in excess
of $50,000, or (iii) injunctive relief of any type or nature against Davis, FHI
or any of its Subsidiaries.

                  3.8      Restrictions on Business Activities. There is no
agreement, judgment, injunction, decree or order binding upon FHI or any of its
Subsidiaries which has or reasonably could be expected to have the effect of
prohibiting or materially impairing any business practice of FHI or any of its
Subsidiaries, any acquisition of property by FHI or any of its Subsidiaries or
the conduct of business by FHI or any of its Subsidiaries. Neither FHI nor any
of its Subsidiaries has been advised by any Person that such Person is
contemplating issuing or requesting (or

                                       14

<PAGE>

is considering the appropriateness of issuing or requesting) any such agreement,
judgment, injunction, decree or order.

                  3.9      Insurance Licenses, Insurance Reports and FHI
Authorizations.

                           (a)      FHI and its Subsidiaries have all valid and
subsisting insurance licenses required to conduct the insurance business
conducted by each of them (the "Insurance Licenses"), and have timely filed all
insurance reports, registrations and statements (together with the Annual
Statements and Quarterly Statements referred to below, the "Insurance Reports"),
required to be obtained by any of them from or filed with the Pennsylvania
Department of Insurance or any other state or foreign insurance licensing
authority (collectively, the "Insurance Authorities"). Copies of all Insurance
Licenses applied for, issued to or held by FHI's Subsidiaries are attached to
Schedule 3.9. All Insurance Reports filed with any Insurance Authority by FHI or
its Subsidiaries complied in all material respects with the applicable statutes,
rules and regulations enforced or promulgated by such Insurance Authority, and
were true, correct and complete in all material respects as so filed therewith.
For each Subsidiary of FHI that conducts an insurance business, the required
annual statutory financial statements (including the notes thereto) (the "Annual
Statements") and the statutory financial statements required to be filed on a
quarterly basis (including the notes thereto) (the "Quarterly Statements") of
each such Subsidiary are and, with respect to Annual Statements and Quarterly
Statements required to be filed after the date hereof and prior to the Effective
Time will be, prepared in conformity with accounting practices prescribed or
permitted by the Insurance Authority of such Subsidiary's state of domicile
("SAAP") consistently applied, and present fairly (or will present fairly), as
of their respective dates, the admitted assets, liabilities and capital and
surplus of each such Subsidiary at the dates stated (or to be stated) therein on
the basis of SAAP consistently applied. Copies of all such Annual Statements and
Quarterly Statements that were required to be filed since January 1, 1998, have
been (and, with respect to any such statements required to be filed after the
date hereof and prior to the Effective Time, will be) provided to Buyer.

                           (b)      Neither FHI nor any of its Subsidiaries has
received any approvals from any Insurance Authority to engage in, within the
last three fiscal years has engaged in, or has sought or plans to seek any
approval to engage in, any "permitted practices" in the preparation, submission
or filing of any Insurance Reports that deviate from SAAP as prescribed by any
such Insurance Authority.

                           (c)      FHI and each of its Subsidiaries has
obtained from each Governmental Entity (other than Insurance Authorities) all
other consents, licenses, permits, grants and other authorizations (i) pursuant
to which FHI or any of its Subsidiaries operates or holds any interest in any of
its properties, or (ii) that is

                                       15

<PAGE>

required for the operation of its business or the holding of any such interest
other than its conduct of the business of insurance (sub-items (i) and (ii)
herein, together with the Insurance Licenses, are collectively referred to as
the "FHI Authorizations"), except where the failure to obtain any such consent,
license, permit, grant or authorization will not have a Material Adverse Effect.
Each of the FHI Authorizations is in full force and effect and will not be
revoked or otherwise adversely affected by the transaction contemplated by this
Agreement.

                           (d)      During the three (3) years prior to the date
hereof, each FHI Subsidiary which conducts an insurance business (a) has not had
its license or qualification to conduct insurance business in any jurisdiction
revoked or suspended or been involved in a proceeding to revoke or suspend such
license or qualification, nor to the best knowledge of FHI and its Subsidiaries
has any investigation been conducted, or is pending, in any such jurisdiction
with a view to revocation or suspension of any such license, and (b) has
complied in all material respects with all laws, regulations and orders of
Insurance Authorities applicable to its businesses and the present use of its
properties, and the business conducted by it, and does not violate in any
material respect any such laws, regulations or orders.

                  3.10     Title to Property. FHI and its Subsidiaries have
good and valid title to all of their respective properties, interests in
properties and assets, real and personal, reflected in the FHI Balance Sheet or
acquired after the FHI Balance Sheet Date (except properties, interests in
properties and assets sold or otherwise disposed of since the FHI Balance Sheet
Date in the ordinary course of business, none of which were material in nature
or amount), or in the case of leased properties and assets, valid leasehold
interests in properties or assets used in the business of FHI and its
Subsidiaries, free and clear of all Liens of any kind or character, except (i)
Liens for current Taxes not yet due and payable, (ii) such imperfections of
title, Liens and easements as do not and will not materially detract from or
interfere with the current or proposed use of the properties subject thereto or
affected thereby, or otherwise materially impair current or proposed business
operations involving such properties, and (iii) Liens securing debt that is
fully reflected on the FHI Balance Sheet and the notes thereto. The plant,
property and equipment of FHI and its Subsidiaries used in their business
operations are, in all material respects, in usable condition and repair,
ordinary wear and tear excepted. All properties used in the business operations
of FHI and its Subsidiaries are reflected in the FHI Balance Sheet to the
extent GAAP requires the same to be reflected thereon. Schedule 3.10 identifies
(i) each parcel of real property owned or leased by FHI or any of its
Subsidiaries, (ii) any items of personal property of FHI or any of its
Subsidiaries utilized by its insurance agents or other third parties under any
lease or bailment requiring annual payments in excess of $5,000 per lease or
bailment, and (iii) all leases of real property.

                                       16

<PAGE>

                  3.11     Intellectual Property.

                           (a)      FHI and its Subsidiaries own, free and clear
of all Liens, or are licensed or otherwise possess legally enforceable rights to
use, all , trademarks, trade names, service marks, domain names, copyrights,
technology, know-how, trade secrets, , computer software programs or
applications, and all other tangible or intangible proprietary information or
material (collectively, "Intellectual Property") used in the business of FHI or
its Subsidiaries, subject to such imperfections in title, license or rights that
would not have a Material Adverse Effect. Schedule 3.11 lists all Intellectual
Property owned or licensed by FHI or its Subsidiaries other than trade secrets.
FHI and its Subsidiaries have not entered into any exclusive Contracts relating
to their Intellectual Property.

                           (b)      To the knowledge of FHI and its
Subsidiaries, there is no and has been no unauthorized use, disclosure,
infringement or misappropriation of any Intellectual Property rights of FHI or
any of its Subsidiaries, or any Third Party Intellectual Property Right of any
third party to the extent licensed by or through FHI or any of its Subsidiaries,
by any Person, including any employee or former employee of FHI or any of its
Subsidiaries. Neither FHI nor any of its Subsidiaries has received a claim or
been sued in any suit, action or proceeding that involves a claim of
infringement of any trademarks, trade names, service marks, domain names,
copyrights or violation of any trade secret or other proprietary right of any
third party. Neither FHI nor any of its Subsidiaries has entered into any
Contract to indemnify any other Person against any charge of infringement of any
Intellectual Property, other than indemnification provisions contained in
purchase orders or licensing agreements entered into in the ordinary course of
business.

                  3.12     Environmental Matters. The following environmental
representations and warranties only apply to actions, occurrences or conditions
arising subsequent to January 1, 1989, unless a more current date is specified.
Except as set forth on Schedule 3.12, (i) since January 1, 1989, to the best of
FHI's knowledge, no methylene chloride or asbestos is contained in or has been
used at or released from the Facilities in violation of Environmental and Safety
Laws; (ii) since January 1, 1989, all Hazardous Materials and wastes have been
disposed of in accordance with all Environmental and Safety Laws in all material
respects; (iii) since January 1, 1989, FHI and its Subsidiaries have received no
notice (verbal or written) of any noncompliance of the Facilities or its past or
present operations with Environmental and Safety Laws; (iv) no notices,
administrative actions or suits are pending or, to FHI's knowledge, threatened
relating to any material violation of any Environmental and Safety Laws; (v)
neither FHI nor any of its Subsidiaries is a potentially responsible party under
the federal Comprehensive Environmental Response, Compensation and Liability Act
("CERCLA"), or similar

                                       17

<PAGE>

state statute, arising out of events occurring since January 1, 1989 and prior
to the Effective Time; (vi) to the best of FHI's knowledge, there have not been
in the past, and are not now, any Hazardous Materials on, under or migrating to
or from the Facilities or Property; (vii) there have not been in the past, and
are not now, any underground tanks or underground improvements at, on or under
the Property including without limitation, treatment or storage tanks, sumps, or
water, gas or oil wells; (viii) there are no polychlorinated biphenyls ("PCBs")
deposited, stored, disposed of or located on the Property or Facilities or any
equipment on the Property containing PCBs at levels in excess of 50 parts per
million; (ix) there is no formaldehyde on the Property or in the Facilities, nor
any insulating material containing urea formaldehyde in the Facilities; (x)
since January 1, 1989, the Facilities and FHI's and its Subsidiaries' uses and
activities therein have at all times complied with all Environmental and Safety
Laws in all material respects; and (xi) FHI and its Subsidiaries have all
material permits and licenses required to be issued under Environmental and
Safety Laws and are in material compliance with the terms and conditions of each
such permit and license.

                  3.13     Taxes. FHI and its Subsidiaries, and any
consolidated, combined, unitary or aggregate group for Tax purposes of which FHI
or any of its Subsidiaries is or has been a member, have timely filed all Tax
Returns required to be filed by them and have paid (or withheld and paid) all
Taxes owed by (or required to be withheld and paid by) FHI and its Subsidiaries
(whether or not shown on any Tax Return), unless appropriately contested thereby
and accrued in the balance sheet contained in the FHI Financial Statements. All
such Tax Returns are complete and accurate in all respects and properly reflect
the Taxes of FHI and its Subsidiaries for the periods covered thereby. FHI has
provided adequate accruals in accordance with GAAP in the FHI Financial
Statements for any Taxes that were not paid as of the date of such financial
statements, whether or not shown as being due on any Tax Return. FHI and its
Subsidiaries are not delinquent in the payment of any Tax, assessment or similar
governmental charge. Neither FHI nor any of its Subsidiaries has received any
notice that any Tax deficiency has been asserted against FHI or any of its
Subsidiaries, and there is no threat of such assertion. There is no unpaid
assessment, deficiency or delinquency in the payment of any Tax that could be
asserted by any Tax Authority. Neither FHI nor any of its Subsidiaries has
violated any applicable federal, state, local or foreign Tax law in any material
respect. Except as disclosed in the FHI Financial Statements, (i) no claim for
Taxes has become a Lien against the property of FHI or any of its Subsidiaries
or is being asserted against FHI or any of its Subsidiaries, (ii) no action,
suit, proceeding, investigation, claim or audit has formally commenced and no
written notification has been given that such audit or other proceeding is
pending or threatened with respect to FHI or any of its Subsidiaries in respect
of any Tax, (iii) no extension or waiver of the statute of limitations on

                                       18

<PAGE>

the assessment or collection of any Tax has been granted by FHI or any of its
Subsidiaries and is currently in effect, and (iv) there is no agreement,
Contract or arrangement to which FHI or any of its Subsidiaries is a party that
may result in the payment of any amount that would not be deductible by reason
of Section 280G, 162 or 404 of the Code. FHI has not been and will not be
required to include any adjustment in Taxable income for any Tax period (or
portion thereof) pursuant to Section 481 of the Code or any comparable provision
under state or foreign Tax laws as a result of transactions, events or
accounting methods employed prior to the transactions contemplated by this
Agreement. Except as set forth on Schedule 3.13, neither FHI nor any of its
Subsidiaries is a party to any tax sharing or tax allocation agreement with any
other entity, nor does FHI or any of its Subsidiaries owe any amount to any
other entity under any such agreement. No consent to the application of Section
341(f)(2) of the Code has been filed with respect to FHI or any of its
Subsidiaries. All Taxes that FHI or any of its Subsidiaries is or was required
to withhold or collect have been duly withheld or collected and, to the extent
required, have been paid to the proper Governmental Entity, Tax Authority or
other Person. FHI and its Subsidiaries will not be required to include any
amount in Taxable income for any Taxable period (or portion thereof) ending
after the Closing Date as a result of a change in the method of accounting for a
Taxable period ending prior to the Closing Date, any "closing agreement" as
described in Section 7121 of the Code (or any corresponding provision of state,
local, or foreign tax laws) entered into prior to the Closing Date, any sale
reported on the installment method that occurred prior to the Closing Date, or
any Taxable income from "excess loss accounts" or "intercompany transactions" as
defined in the Code or the applicable Treasury Regulations (or any corresponding
provision of state, local or foreign tax laws). Schedule 3.13 sets forth a
reasonably detailed description of the nature of any pending audit relating to
Taxes. No claim has been made by a Tax Authority in any jurisdiction in which
FHI or any of its Subsidiaries does not file Tax Returns that FHI or any of its
Subsidiaries is required to file Tax Returns in such jurisdiction and, to the
knowledge of FHI and its Subsidiaries, no Tax Authority could reasonably make
any such claim.

                  3.14     Employee Benefit Plans.

                           (a)      Schedule 3.14 lists (i) all employee benefit
plans (as defined in Section 3(3) of the Employee Retirement Income Security Act
of 1974, as amended ("ERISA")) and related trusts that are maintained or
contributed to by FHI or any of its Subsidiaries or with respect to which FHI or
any of its Subsidiaries has any liability or obligation to contribute, (ii) each
loan to a non-officer employee or former employee of FHI or any of its
Subsidiaries, loans to officers and directors of FHI or any of its Subsidiaries
and any stock option, stock purchase, phantom stock, stock appreciation right,
severance, sabbatical, employee

                                       19

<PAGE>

relocation, cafeteria benefit (Code Section 125) or dependent care (Code Section
129), or accident insurance plans, programs or arrangements benefiting employees
or former employees of FHI or any of its Subsidiaries, (iii) all bonus, profit
sharing, savings, deferred compensation or incentive plans, programs or
arrangements benefiting employees or former employees of FHI or any of its
Subsidiaries, (iv) other fringe or employee benefit plans, programs or
arrangements that apply to management and other employees of FHI or any of its
Subsidiaries, and (v) any current or former employment or executive compensation
or severance agreements, written or otherwise, as to which unsatisfied
obligations (exclusive of an obligation to pay for ongoing services) of FHI or
any of its Subsidiaries of greater than $25,000 remain for the benefit of, or
relating to, any present or former employee, consultant or director of FHI or
any of its Subsidiaries (together, the "FHI Employee Plans").

                           (b)      FHI has furnished to Buyer a copy of each of
the FHI Employee Plans and related plan documents (including trust documents,
insurance policies or contracts with third party administrators, actuaries,
investment managers, consultants and all independent contractors related to such
FHI Employee Plans, employee booklets, employment manuals, policy manuals,
summary plan descriptions and other authorizing documents, and any material
employee communications relating thereto), the most recent actuarial report,
where applicable, and has, with respect to each FHI Employee Plan that is
subject to ERISA reporting requirements, provided copies of the Form 5500
reports filed for the last three plan years. Any FHI Employee Plan intended to
be qualified under Section 401(a) of the Code has either obtained from the
Internal Revenue Service a favorable determination letter as to its qualified
status under the Code, including all amendments to the Code effected by the Tax
Reform Act of 1986 and subsequent legislation, or has applied to the Internal
Revenue Service for such a determination letter prior to the expiration of the
requisite period under applicable Treasury Regulations or Internal Revenue
Service pronouncements in which to apply for such determination letter and to
make any amendments necessary to obtain a favorable determination. FHI has
furnished Buyer with the most recent Internal Revenue Service determination
letter issued with respect to each such FHI Employee Plan, and nothing has
occurred since the issuance of each such letter that would be reasonably
expected to cause the loss of the tax qualified status of any FHI Employee Plan
subject to Code Section 401(a).

                           (c)      (i) No FHI Employee Plan promises or
provides retiree medical or other retiree welfare benefits to any Person, except
as required by applicable law; (ii) there has been no "prohibited transaction,"
as such term is defined in Section 406 of ERISA and Section 4975 of the Code,
with respect to any FHI Employee Plan; (iii) each FHI Employee Plan has been
administered, in

                                       20

<PAGE>

all material respects, in accordance with its terms and in compliance with the
requirements prescribed by any and all statutes, rules and regulations
(including ERISA and the Code), and FHI and each of its Subsidiaries have
performed all obligations required to be performed by them under, are not in any
material respect in default under or violation of, and have no knowledge of any
default or in violation by any other party to, and are otherwise in full
compliance with ERISA, the Code and other applicable laws with respect to any of
the FHI Employee Plans; (iv) neither FHI nor any of its Subsidiaries is subject
to any liability or penalty under Sections 4971 through 4980E of the Code or
Title I of ERISA with respect to any of the FHI Employee Plans; (v) all
contributions required to be made by FHI or any of its Subsidiaries to any FHI
Employee Plan have been made on or before their due dates and the full amount
required has been accrued for contributions to each FHI Employee Plan for the
current plan years; (vi) with respect to each FHI Employee Plan, no "reportable
event" within the meaning of Section 4043 of ERISA (excluding any such event for
which the thirty (30) day notice requirement has been waived under the
regulations to Section 4043 of ERISA) nor any event described in Section 4062,
4063 or 4041 of ERISA has occurred; (vii) no FHI Employee Plan is covered by,
and neither FHI nor any of its Subsidiaries nor any trade or business (whether
or not incorporated) that is, or at any time within the six-year period
preceding the date of this Agreement, was treated as a single employer with FHI
(an "ERISA Affiliate") within the meaning of Section 414(b), (c), (n) or (o) of
the Code, maintains or contributes to or at any time within the six-year period
preceding the date of this Agreement maintained or contributed to or had an
obligation to contribute to any employee benefit plan covered by or has incurred
or expects to incur any liability under Part 3 of Subtitle B of Title I of
ERISA, Title IV of ERISA or Section 412 of the Code; (viii) each FHI Employee
Plan can be amended, terminated or otherwise discontinued after the Effective
Time in accordance with its terms, without liability to Buyer and without any
additional accrual on the books of FHI or any of its Subsidiaries; and (ix) no
FHI Employee Plan promises or provides benefits to any of FHI's or its
Subsidiaries' independent contractors or subcontractors. With respect to each
FHI Employee Plan subject to ERISA as either an employee pension plan within the
meaning of Section 3(2) of ERISA or an employee welfare benefit plan within the
meaning of Section 3(1) of ERISA, FHI has prepared in good faith and timely
filed all requisite governmental reports (which were true and correct in all
material respects as of the date filed) and has properly and timely filed and
distributed or posted all notices and reports to employees required to be filed,
distributed or posted with respect to each such FHI Employee Plan. No suit,
administrative proceeding, action or other litigation has been brought, or to
the knowledge of FHI or its Subsidiaries is threatened, against or with respect
to any such FHI Employee Plan, including any audit or inquiry by the IRS or
United States Department of Labor. No payment or benefit that will or may be
made by FHI or any of its Subsidiaries

                                       21

<PAGE>

to any employee will be characterized as an "excess parachute payment" within
the meaning of Section 280G(b)(1) of the Code.

                           (d)      The consummation of the transactions
contemplated by this Agreement will not (i) entitle any current or former
employee or other service provider of FHI, any of its Subsidiaries or any other
ERISA Affiliate to severance benefits or any other payment, except as expressly
provided in this Agreement, or (ii) accelerate the time of payment or vesting,
or increase the amount of compensation due any such employee or service
provider.

                           (e)      There has been no amendment to, written
interpretation or announcement (whether or not written) by FHI or any of its
Subsidiaries relating to, or change in participation or coverage under, any FHI
Employee Plan that would materially increase the expense of maintaining such
Plan above the level of expense incurred with respect to that Plan as reflected
in the FHI Financial Statements for the most recently completed fiscal year.

                  3.15     Certain Agreements Affected. Except as set forth on
Schedule 3.15, neither the execution and delivery of this Agreement nor the
consummation of the transactions contemplated hereby will (i) result in any
payment (including severance, unemployment compensation, golden parachute, bonus
or otherwise) becoming due to any director or employee of FHI or any of its
Subsidiaries, (ii) materially increase any benefits otherwise payable by FHI, or
(iii) result in the acceleration of the time of payment or vesting of any such
benefits.

                  3.16     Employees and Insurance Agents.

                           (a)      Schedule 3.16 sets forth (i) information
regarding (including copies of Contracts with) all managing general agents with
underwriting authority on behalf of FHI's Subsidiaries, and (ii) names, annual
rates of salary, bonus, profit-sharing, incentive compensation, employee
benefits and other material compensation of all present officers, directors,
employees, agents (including insurance agents) and independent contractors of
FHI and its Subsidiaries (other than employees of FHI or its Subsidiaries with
aggregate compensation of less than $40,000 reported on their 1999 Forms W-2 as
reported to the Internal Revenue Service) paid by FHI or its Subsidiaries.
Schedule 3.16 also sets forth all loans and advances (other than routine travel
advances to be repaid or formally accounted for within thirty days and reflected
on the books of FHI) made by FHI or any of its Subsidiaries to employees or
agents (including insurance agents) since the FHI Balance Sheet Date. FHI and
its Subsidiaries are in compliance in all material respects with all applicable
laws and regulations respecting employment, discrimination in employment, terms
and conditions of employment, wages, hours and occupational safety and health
and employment

                                       22

<PAGE>

practices, and is not engaged in any unfair labor practice. FHI and its
Subsidiaries have withheld all amounts required by law or by Contract to be
withheld from the wages, salaries and other payments to employees; and are not
liable for any arrears of wages or any Taxes or any penalty for failure to
comply with any of the foregoing. FHI and its Subsidiaries are not liable for
any material payment to any trust or other fund or to any Governmental Entity
with respect to unemployment compensation benefits, social security or other
benefits or obligations for employees (other than routine payments to be made in
the normal course of business and consistent with past practice). There are no
pending claims against FHI or any of its Subsidiaries for any material amounts
under any workers compensation plan or policy or for long term disability.
Neither FHI nor any of its Subsidiaries has any obligations under COBRA with
respect to any former employees or qualifying beneficiaries thereunder, except
for obligations that are not material in amount. There are no actions, suits,
proceedings, claims, arbitrations or investigations pending by or before any
Governmental Entity regarding employee claims against FHI or any of its
Subsidiaries. Neither FHI nor any of its Subsidiaries is a party to any
collective bargaining agreement or other labor union contract, nor does FHI or
any of its Subsidiaries have knowledge of any activities or proceedings of any
labor union to organize any such employees. To the knowledge of FHI and its
Subsidiaries, no employees of FHI or any of its Subsidiaries are in material
violation of any term of an employment contract, noncompetition agreement, or
restrictive covenant to a former employer relating to the right of any such
employee to be employed by FHI or any of its Subsidiaries because of the nature
of the business conducted by FHI or any of its Subsidiaries or to the use of
trade secrets or proprietary information of others.

                           (b)      FHI and its Subsidiaries conduct their
insurance business solely through the American independent agency system, and
none of them is engaged in any direct sales of insurance products to customers
by way of the Internet or any other direct-writing distribution arrangement.
FHI's relationships with its independent agents can reasonably be characterized
as good, and no agent (or group of agents) that accounted for more than one
percent (1%) of the insurance premium of FHI and its Subsidiaries during the
fiscal year ended December 31, 1999, has indicated to FHI or any of its
Subsidiaries that it will discontinue or materially decrease its level of
business written with any of FHI's Subsidiaries, whether as a result of the
transactions contemplated by this Agreement or otherwise. Schedule 3.16
identifies each managing general agent engaged by any FHI Subsidiary in its
business of insurance and the nature of the business relationship therewith. FHI
has separately delivered to Buyer the Bonus Commission Agreement with Davis
Insurance Agency, Inc.

                                       23

<PAGE>

                  3.17     Interested Party Transactions . Except as disclosed
in Schedule 3.17, (i) neither FHI nor any of its Subsidiaries is indebted to any
director or officer of FHI or any of its Subsidiaries (except for amounts due as
normal salaries and bonuses and in reimbursement of ordinary expenses), and (ii)
no such Person is indebted to FHI or any of its Subsidiaries.

                  3.18     Insurance. Schedule 3.18 lists all insurance policies
owned or held by FHI and its Subsidiaries. All such insurance policies are in
full force and effect, all premiums with respect thereto covering all periods up
to and including the date hereof have been paid to the extent due and no notice
of cancellation or termination has been received with respect to any such
policy.

                  3.19     Books and Records. The books of account of FHI and
its Subsidiaries reflect all material items of income and expense and all
material assets, liabilities and accruals, and are prepared and maintained in
form and substance adequate for preparing audited financial statements in
accordance with GAAP and in accordance with SAAP as prescribed or permitted by
the Pennsylvania Department of Insurance. The minute books of FHI and its
Subsidiaries have been provided to Buyer and contain complete and accurate
summaries of all meetings of directors and stockholders or actions by written
consent since the time of incorporation of FHI and its respective Subsidiaries
through the date of this Agreement, and reflect all transactions referred to in
such minutes accurately in all material respects. Such minutes or consents have
not been rescinded or amended except as reflected in such minute books.

                  3.20     Complete Copies of Materials. FHI has delivered true
and complete copies of each document that has been requested by Buyer, its
counsel and its accountants in connection with their business, legal and
accounting review of FHI and its Subsidiaries.

                  3.21     Brokers' and Finders' Fees. Except for a payment
obligation to CIC, Inc. to be paid equally by Buyer and FHI, FHI and its
Subsidiaries have not incurred, nor will they incur, directly or indirectly, any
liability for brokerage or finders' fees or agents' commissions or investment
bankers' fees or any similar charges in connection with this Agreement or any
transaction contemplated hereby.

                  3.22     No Stockholder Vote. No vote of the holders of any
class of FHI Capital Stock is necessary to approve this Agreement and the
transactions contemplated hereby.

                  3.23     Agreements. Schedule 3.23 contains a true and
complete list of all oral and written Contracts to which FHI or any of its
Subsidiaries is a party or by which any of their properties or assets may be
bound and which (a) involve

                                       24

<PAGE>

obligations by any party thereto in excess of $50,000; (b) contain any provision
or option relating to the sale by FHI or any of its Subsidiaries of any business
or material assets; or (c) are Contracts to which any Governmental Entity is a
party; provided, that notwithstanding the foregoing provisions of this Section
3.23, the FHI Disclosure Schedule need not list, and for such purpose the term
"Contracts" shall not include, agreements for which the obligations of the
parties thereto have been completely fulfilled or which are listed on any other
schedule. All Contracts required to be disclosed on Schedule 3.23 were entered
into by FHI or its Subsidiaries in the ordinary course of business (except as
otherwise indicated thereon), are valid and binding and in full force and effect
with respect to FHI or any Subsidiary of FHI that is a party thereto and each of
the other parties thereto, and there exists no material breach or default by FHI
or any of its Subsidiaries that is a party thereto or any claim of such a breach
or default, or any event which, with notice or lapse of time or both, would
constitute a material breach or default by FHI or any of its Subsidiaries that
is a party thereto. Except as set forth on Schedule 3.23, the execution,
delivery and performance of this Agreement will not cause or result in a breach
or default, or result in termination or modification, with or without notice or
consent, of any Contract required to be disclosed on Schedule 3.23. FHI has
provided to Buyer true and complete copies, including amendments, modifications
and assignments relating thereto, of all such written Contracts and true and
correct summaries of all such oral Contracts.

                  3.24     Certain Acts. Neither FHI nor any of its Subsidiaries
nor, to the knowledge of FHI or Davis, any of their former or current officers,
directors, employees, agents or representatives, has, directly or indirectly,
(a) made any contribution, gift, bribe, rebate, payoff, influence payment,
kickback or other payment to any Person, private or public, regardless of form,
whether in money, property or services (i) to obtain favorable treatment in
securing and maintaining business or any FHI Authorizations, (ii) to pay for
favorable treatment for business secured, (iii) to obtain special concessions or
for special concessions already obtained, for or in respect of FHI or any of its
Subsidiaries or Affiliates, or (iv) in violation of any laws, or (b) established
or maintained any fund or asset that, in accordance with generally accepted
accounting principles, should have been and has not been recorded in the books
and records of FHI.

                  3.25     Banking Information. Schedule 3.25 contains a list of
all bank accounts, custodial accounts and credit facilities and authorized
signatories on bank accounts, custodial accounts and credit facilities of FHI
and its Subsidiaries. No Person other than as listed on Schedule 3.25 is
authorized to withdraw any funds on such bank accounts or custodial accounts or
to draw down on such credit facilities.

                                       25

<PAGE>

                  3.26     Loss Reserves. FHI has provided to Buyer its
independent actuary's opinion and analysis of the loss reserves of FHI and its
Subsidiaries as of December 31, 2000, and will provide its independent actuary's
opinion and analysis of such loss reserves as of March 31, 2001, as soon as
available prior to the Effective Time. From the FHI Balance Sheet Date through
the Closing Date, FHI and its Subsidiaries have reserved and will continue to
reserve against losses in a manner consistent with past practice.

                  3.27     Insurance Policies; Reinsurance.

                           (a)      Schedule 3.27 contains a true and complete
list of all types of insurance policies issued by FHI's Subsidiaries in any
jurisdiction. FHI has made available to Buyer true and complete copies of all
forms of insurance policies of FHI's Subsidiaries together with all forms of
endorsements thereto (other than policies or endorsements issued on forms
prepared by the Insurance Services Office).

                           (b)      Schedule 3.27 contains a true and complete
list of all reinsurance agreements to which FHI or any of its Subsidiaries is a
party and to which any of them has been a party since January 1, 1998. Copies of
all such reinsurance agreements have been made available to Buyer. The
consummation of the transactions contemplated by this Agreement will not,
without the Buyer's consent, adversely affect, limit or terminate the continuing
obligations of reinsurers under such reinsurance agreements.

                           (c)      Except as disclosed on Schedule 3.27, to the
knowledge of FHI and its Subsidiaries (i) no material default of any party under
any reinsurance agreement required to be listed on Schedule 3.27 has occurred
and no basis exists for the declaration of any default or termination right
thereunder, except for agreements which, prior to the Closing, have or will have
expired by their terms, and (ii) each party to any reinsurance agreement
required to be listed on Schedule 3.27 was, at the date such reinsurance
agreement was executed and delivered, solvent and financially capable of
fulfilling its obligations to FHI or its Subsidiaries thereunder.

                  3.28     Data Processing Matters. Except as otherwise set
forth on Schedule 3.28:

                           (a)      FHI and its Subsidiaries do not have any of
their respective records, systems, controls, data or information recorded,
stored, maintained, operated or otherwise wholly or partly dependent upon or
held by any means (including any electronic, mechanical or photographic process,
whether

                                       26

<PAGE>

computerized or not) that (including all means of access thereto and therefrom)
are not under the exclusive ownership and direct control of FHI and its
Subsidiaries.

                           (b)      FHI and its Subsidiaries own, lease or
license certain computer equipment, associated peripheral devices, and related
operating and application systems and other software utilized in connection with
their business and operations (collectively, the "Data Processing Systems"). FHI
and its Subsidiaries have not been advised by any consultant or other third
party that the Data Processing Systems do not adequately meet the data
processing needs of FHI and its Subsidiaries and their operations as presently
conducted in any material respect.

                           (c)      FHI and its Subsidiaries have taken
appropriate action by instruction, agreement or otherwise with its employees or
other Persons permitted access to system application programs and data files
used in the Data Processing Systems to protect against unauthorized access, use,
copying, modification, theft and destruction of such programs and files, to the
extent usual and customary. FHI and its Subsidiaries have not sustained
disruption of business or loss by reason of unauthorized access, use, copying,
modification, theft or destruction of such programs and files by its current or
former employees or other Persons permitted access thereto.

                           (d)      The data processing and data storage
facilities of FHI and its Subsidiaries are adequate, properly protected and
possess proper temperature and humidity control devices and fire protection
equipment.

                           (e)      FHI and its Subsidiaries have arranged for
back-up data processing services in the event that the Data Processing Systems
or any component thereof are rendered temporarily or permanently inoperative as
a result of a natural or other disaster.

                  3.29     Ownership of Class A Stock and Options. Davis owns
beneficially and of record all outstanding shares of Class A Stock and Options
free and clear of any Liens, except the Bank Pledge. Except as set forth in the
Shareholder Documents or on Schedule 3.30, there are no outstanding voting
agreements or proxies, or other commitments or agreements of any character
relating to the Class A Stock or Options or otherwise obligating Davis to
transfer, sell, purchase or redeem any shares of Class A Stock or Options.

                  3.30     Representations Complete. No statement, certificate,
instrument or other writing furnished or to be furnished by FHI pursuant to this
Agreement or any Schedule or Exhibit hereto, including the FHI Disclosure
Schedule, or any certificate, instrument or other writing furnished or to be

                                       27

<PAGE>

furnished by FHI pursuant thereto, contains or will contain at the Effective
Time any untrue statement of a material fact, or when taken together omit or
will omit at the Effective Time to state any material fact necessary in order to
make the statements contained herein or therein, in the light of the
circumstances under which made, not misleading.

                                  ARTICLE IV -

                     REPRESENTATIONS AND WARRANTIES OF BUYER

         Buyer hereby represent and warrant to FHI as follows:

                  4.1      Organization, Standing and Power. Buyer is a
corporation duly organized, validly existing and in good standing under the laws
of the Commonwealth of Pennsylvania. Buyer has the requisite corporate power to
own its properties and to carry on its business as now being conducted and as
proposed to be conducted and is duly qualified to do business and is in good
standing in each jurisdiction where its ownership or leasing of property or the
conduct of its business requires it to be so qualified. Buyer is not in
violation of any of the provisions of its Articles of Incorporation or Bylaws.

                  4.2      Authority. Buyer has all requisite corporate power
and authority to enter into this Agreement and to consummate the transactions
contemplated hereby. The execution and delivery of this Agreement and the
consummation of the transactions contemplated hereby and thereby have been duly
authorized by all necessary corporate action on the part of Buyer. This
Agreement has been duly executed and delivered by Buyer and constitutes the
valid and binding obligations of Buyer enforceable against Buyer in accordance
with its terms, except as enforceability may be limited by bankruptcy and other
laws affecting the rights and remedies of creditors generally and general
principles of equity. The execution and delivery of this Agreement does not, and
will not, and the consummation of the transactions contemplated hereby will not,
conflict with, or result in any violation of, or default under (with or without
notice or lapse of time, or both), or give rise to a right of termination,
amendment, cancellation or acceleration of any obligation or loss of a benefit
under (i) any provision of the Articles of Incorporation or Bylaws of Buyer, or
(ii) any Contract, permit, concession, franchise, license, judgment, order,
decree, statute, law, ordinance, rule or regulation applicable to Buyer or any
of its properties or assets, or to which Buyer or any of its properties or
assets is subject or bound or that give rise to any Liens. No consent, approval,
order or authorization of, or registration, declaration or filing with, any
Governmental Entity, is required by or with respect to Buyer in connection with
the execution and delivery of this Agreement or the consummation by Buyer of the
transactions contemplated hereby, except for the filing of a Form

                                       28

<PAGE>

A with the Pennsylvania Department of Insurance and the obtaining of approval
therefrom.

                  4.3      Litigation. There is no agreement, judgment,
injunction, decree or order against Buyer or any of its Subsidiaries, or, to the
knowledge of Buyer and its Subsidiaries, any of their respective directors or
officers (in their capacities as such) that would prevent, enjoin, alter or
materially delay any of the transactions contemplated by this Agreement, or that
has or could reasonably be expected to have a Material Adverse Effect on the
ability of Buyer to consummate the transactions contemplated by this Agreement.
Neither Buyer nor any of its Affiliates has been advised by a Person that such
Person is contemplating issuing or requesting (or is considering the
appropriateness of issuing or requesting) any such agreement, judgment,
injunction, decree or order.

                  4.4      Broker's and Finders' Fees. Except for a payment
obligation to CIC, Inc. to be paid equally by Buyer and FHI, Buyer has not
incurred, nor will it incur, directly or indirectly, any liability for brokerage
or finders' fees or agents' commissions or investment bankers' fees or any
similar charges in connection with this Agreement or any transaction
contemplated hereby.

                  4.5      Board Approval. The Board of Directors of Buyer has
approved this Agreement.

                  4.6      Financial Capability. Buyer has and shall have, as of
the Effective Time, sufficient funds to consummate the transactions contemplated
by this Agreement.

                  4.7      Insurance Licenses, Insurance Reports and
Authorizations.

                           (a)      Buyer and its Affiliates have all valid and
subsisting insurance licenses required to conduct the insurance business
conducted by each of them (the "Insurance Licenses"), and have timely filed all
insurance reports, registrations and statements (together with the Annual
Statements and Quarterly Statements referred to below, the "Insurance Reports"),
required to be obtained by any of them from or filed with the Pennsylvania
Department of Insurance or any other state or foreign insurance licensing
authority (collectively, the "Insurance Authorities"). All Insurance Reports
filed with any Insurance Authority by Buyer or its Affiliates complied in all
material respects with the applicable statutes, rules and regulations enforced
or promulgated by such Insurance Authority, and were true, correct and complete
in all material respects as so filed therewith. For Buyer and its Affiliates
that conduct an insurance business, the required annual statutory financial
statements (including the notes thereto) (the "Annual Statements") and the
statutory financial statements required to be filed on a quarterly basis

                                       29

<PAGE>

(including the notes thereto) (the "Quarterly Statements") of each are and, with
respect to Annual Statements and Quarterly Statements required to be filed after
the date hereof and prior to the Effective Time will be, prepared in conformity
with accounting practices prescribed or permitted by the Insurance Authority of
its state of domicile ("SAAP") consistently applied, and present fairly (or will
present fairly) as of their respective dates the admitted assets, liabilities
and capital and surplus of each at the dates stated (or to be stated) therein on
the basis of SAAP consistently applied. Copies of the most recent Annual
Statement have been (and, with respect to any Insurance Reports required to be
filed after the date hereof and prior to the Effective Time, will be ) provided
to FHI.

                           (b)      Neither Buyer nor any of its Affiliates has
received any approvals from any Insurance Authority to engage in, within the
last three fiscal years has engaged in, or has sought or plans to seek any
approval to engage in, any "permitted practices" in the preparation, submission
or filing of any Insurance Reports that deviate from SAAP as prescribed by any
such Insurance Authority.

                           (c)      During the three (3) years prior to the date
hereof, Buyer and each Affiliate that conducts an insurance business (i) has not
had its license or qualification to conduct insurance business in any
jurisdiction revoked or suspended or been involved in a proceeding to revoke or
suspend such license or qualification, nor to the best knowledge of Buyer has
any investigation been conducted, or is pending, in any such jurisdiction with a
view to revocation or suspension of any such license, and (ii) has complied in
all material respects with all laws, regulations and order of Insurance
Authorities applicable to its businesses and the present use of its properties,
and the business conducted by it, and does not violate in any material respect
any such laws, regulations or orders.

                  4.8      Representations Complete. No statement, certificate,
instrument or other writing furnished or to be furnished by Buyer pursuant to
this Agreement, or any certificate furnished or to be furnished by Buyer
pursuant to this Agreement, contains or will contain at the Effective Time any
untrue statement of a material fact, or omits or will omit at the Effective Time
to state any material fact necessary in order to make the statements contained
herein or therein, in the light of the circumstances under which made, not
misleading.

                                   ARTICLE V -

                       CONDUCT PRIOR TO THE EFFECTIVE TIME

                  5.1      Conduct of Business of FHI. Prior to the Closing, FHI
shall, and shall cause its Subsidiaries to (except to the extent expressly
contemplated by this Agreement or as consented to in writing by Buyer), carry on
its and its

                                       30

<PAGE>

Subsidiaries' business in the usual, regular and ordinary course in
substantially the same manner as heretofore conducted, to pay and to cause its
Subsidiaries to pay debts and Taxes when due subject to good faith disputes over
such debts or Taxes, to pay or perform other obligations when due, and to use
all reasonable efforts consistent with past practice and policies to preserve
intact its and its Subsidiaries' present business organizations, use its
reasonable best efforts consistent with past practice to keep available the
services of its and its Subsidiaries' present officers and key employees and use
its reasonable best efforts consistent with past practice to preserve its and
its Subsidiaries' relationships with all insurance regulatory authorities,
independent insurance agents, reinsurers, customers, suppliers, licensors,
licensees and others having business dealings with it or its Subsidiaries, such
that its and its Subsidiaries' goodwill and ongoing businesses shall not be
materially impaired at the Effective Time. Davis and FHI shall promptly notify
Buyer of any event or occurrence (i) not in the ordinary course of FHI or its
Subsidiaries' business, (ii) that would result in a breach of any covenant or
agreement of FHI or any of its Subsidiaries set forth in this Agreement, (iii)
that would cause any representation or warranty of FHI in this Agreement to be
untrue as of the date of such event or occurrence, or (iv) that would have a
Material Adverse Effect on FHI or any of its Subsidiaries. If the event or
occurrence results or would likely result in a Material Adverse Effect and has
not been cured as provided in Section 8.1(c), then Buyer shall have the right to
terminate this Agreement pursuant to Section 8.1(c). If such right is not
exercised and the event or occurrence was not willful or intentional on the part
of Davis, then the notice shall constitute a permitted amendment to the
Disclosure Schedule, with respect to which no claim may be made by the Buyer.

                  5.2      Negative Covenants. Except as expressly contemplated
by this Agreement, FHI shall not do, cause or permit any of the following, or
allow, cause or permit any of its Subsidiaries to do, cause or permit any of the
following, without the prior written consent of Buyer:

                           (a)      Charter Documents. Amend the Certificate of
Incorporation, Bylaws or equivalent organizational documents of FHI or any of
FHI's Subsidiaries, except that FHI shall amend its Certificate of Incorporation
to increase the authorized number of shares of Class B Stock to 1,200,000
shares;

                           (b)      Dividends; Changes in Capital Stock. Declare
or pay any dividends on or make any other distributions (whether in cash, stock
or property) in respect of any class of FHI Capital Stock, or split, combine or
reclassify any class of FHI Capital Stock or issue or authorize the issuance of
any other securities in respect of, in lieu of or in substitution for shares of
FHI Capital Stock, or purchase, repurchase or otherwise acquire, directly or
indirectly, any shares of FHI

                                       31

<PAGE>

Capital Stock, except that FHI may pay quarterly dividends at the annual rate of
$5.00 per share on the Series A Preferred Stock (in cash or in kind) and the
Series B Preferred Stock;

                           (c)      FHI Stock Options. Take any action to
accelerate, amend or change the period of exercisability or vesting of options
or other rights otherwise granted to acquire shares of FHI Capital Stock or any
benefit plan or authorize cash payments in exchange for any options or other
rights granted, except that FHI shall exchange all options held by Davis to
acquire 590,000 shares of Class A Stock for options to acquire 590,000 shares of
Class B Stock;

                           (d)      Material Contracts. Enter into any Contract
or commitment, or violate, terminate, amend or otherwise modify or waive any of
the terms of any of its Contracts, other than in the ordinary course of business
consistent with past practice, and shall not enter into or modify in any
material respect any Contracts or commitments with managing general agents
without the prior written consent of Buyer, which consent shall not be
unreasonably withheld;

                           (e)      Issuance of Securities. Issue, deliver or
sell or authorize or propose the issuance, delivery or sale of, or purchase or
propose the purchase of, any shares of FHI Capital Stock or securities
convertible into shares of FHI Capital Stock, or subscriptions, rights, warrants
or options to acquire, or other agreements or commitments of any character
obligating it to issue any such shares or other convertible securities (other
than the exchange of options to acquire shares of Class A Stock for options to
acquire shares of Class B Stock) or modify any outstanding securities
convertible into shares of FHI Capital Stock or subscription rights, warrants or
options to acquire, or other agreements or commitments of any character
obligating it to issue such shares or other convertible securities other than
with the consent of the Buyer to give effect to the consents referred to in
Section 7.1(g);

                           (f)      Intellectual Property. Transfer or license
to any Person or otherwise extend, amend or modify any rights to its
Intellectual Property other than in the ordinary course of business consistent
with past practice;

                           (g)      Exclusive Rights. Enter into or amend any
agreements pursuant to which any other party is granted exclusive marketing,
servicing, or other exclusive rights of any type or scope with respect to any of
its services, products, processes or technology;

                           (h)      Dispositions. Sell, lease, license or
otherwise dispose of or encumber any properties or assets which are material,
individually or in the

                                       32

<PAGE>

aggregate, to its and its Subsidiaries' business, except in the ordinary course
of business consistent with past practice;

                           (i)      Indebtedness. Incur any indebtedness for
borrowed money or guarantee any such indebtedness or issue or sell any debt
securities or warrants or rights to acquire debt securities or guarantee any
debt securities of others;

                           (j)      Payment of Obligations. Pay, discharge,
satisfy, settle or compromise any amount in excess of $25,000 in any case,
claim, liability or obligation (absolute, accrued, asserted or unasserted,
contingent or otherwise), other than claims of or against insurance
policyholders arising in the ordinary course of business consistent with past
practice, and payment, discharge or satisfaction of liabilities reflected or
reserved against in the FHI Financial Statements;

                           (k)      Capital Expenditures. Make any capital
expenditures, capital additions or capital improvements in excess of $25,000;

                           (l)      Insurance and Reinsurance. Except as
described on Schedule 5.1(l), materially reduce the amount of any insurance
coverage provided by existing insurance policies or materially modify the
nature, terms or amounts of existing reinsurance;

                           (m)      Reserves. Modify or readjust any insurance
reserves of any kind or nature, other than in the ordinary course of business
consistent with past practice;

                           (n)      Termination or Waiver. Terminate or waive
any right of substantial value, other than in the ordinary course of business;

                           (o)      Employee Benefit Plans; New Hires; Pay
Increases. Enter into any collective bargaining agreement; establish, adopt,
enter into or amend in any material respect any bonus, profit sharing, thrift,
compensation, stock option, restricted stock, pension, retirement, deferred
compensation, employment, termination, severance or other plan, trust, fund,
policy or arrangement for the benefit of directors, officers or employees; hire
any new officer level employee, pay any special bonus or special remuneration to
any employee or director, or increase the salaries or wage rates of employees
other than pursuant to ordinary annual employee reviews consistent with past
practice;

                           (p)      Severance Arrangements. Grant or increase
any severance or termination pay to, or enter into any employment, severance or
termination agreement with, (i) any director or officer, or (ii) any other
employee

                                       33

<PAGE>

except payments made pursuant to standard written agreements outstanding on the
date hereof and disclosed on the FHI Disclosure Schedule.

                           (q)      Lawsuits. Commence a lawsuit other than (i)
for the routine collection of bills, (iii) in connection with the ordinary
course of its claims settlement practices, (iii) in such cases where it in good
faith determines failure to commence suit would result in material impairment of
a valuable aspect of its business, provided that FHI consults with Buyer prior
to the filing of such a suit, or (iii) for a breach of this Agreement;

                           (r)      Acquisitions. Except pursuant to those
Contracts referred to in the FHI Disclosure Schedule, acquire or agree to
acquire by merger or consolidation with, by purchasing an equity interest in or
a material portion of the assets of, or by any other manner, any business or any
Person or division thereof, or otherwise acquire or agree to acquire any assets
that are material, individually or in the aggregate, to its and its
Subsidiaries' business, or acquire or agree to acquire any equity securities of
any Person, other than in the ordinary course of managing its investment
portfolio consistent with past practice;

                           (s)      Taxes. Make or change any election in
respect of Taxes, adopt or change any accounting method in respect of Taxes,
file any Tax Return or any amendment to a Tax Return (other than in the ordinary
course of business consistent with past practice), enter into any closing
agreement, settle any claim or assessment in respect of Taxes, or consent to any
extension or waiver of a limitation period applicable to any claim or assessment
in respect of Taxes;

                           (t)      Notices. Fail to give any notice or provide
other information required by applicable law to be given to the employees of FHI
and any applicable Governmental Entity under the National Labor Relations Act,
the Code, or other applicable law in connection with the transactions provided
for in this Agreement;

                           (u)      Revaluation. Revalue any of its assets,
including writing off notes or accounts receivable other than in the ordinary
course of business consistent with past practice;

                           (v)      Restrictive Agreements. Enter into any
agreement with any Person limiting in any manner the territory or scope of
business activities which FHI or any of its Subsidiaries may engage;

                           (w)      New Subsidiaries. Form any new Subsidiary;
or

                           (x)      Other. Take or agree in writing to take (i)
any of the actions described in Sections 5.1(a) through (w), or (ii) any action
that would make

                                       34

<PAGE>

any of its representations or warranties contained in this Agreement untrue or
incorrect or could prevent it from performing or cause it not to perform its
covenants and obligations hereunder.

                  5.3      No Solicitation. The Selling Shareholders, FHI and
its Subsidiaries and their officers, directors, employees or other agents will
not, directly or indirectly, (i) take any action to solicit, initiate or
encourage any Takeover Proposal (as defined in Section 8.3(f)), or (ii) subject
to the terms of the immediately following sentence, engage in negotiations with,
or disclose any nonpublic information relating to FHI or any of its Subsidiaries
to, or afford access to the properties, books or records of FHI or any of its
Subsidiaries to, any Person that has advised FHI that it may be considering
making, or that has made, a Takeover Proposal. Notwithstanding the immediately
preceding sentence, if an unsolicited written Takeover Proposal shall be
received by the Board of Directors of FHI, then, to the extent the Board of
Directors of FHI believes in good faith (after written advice from an
independent financial advisor) that such Takeover Proposal would, if
consummated, result in a transaction materially more favorable to FHI's
stockholders from a financial point of view than the transactions contemplated
by this Agreement (any such more favorable Takeover Proposal being referred to
in this Agreement as a "Superior Proposal"), and the Board of Directors of FHI
determines in good faith after written advice from outside legal counsel that,
in such outside legal counsel's judgment, there is a reasonable basis for the
Board of Directors of FHI, in order to comply with its fiduciary duties under
applicable Delaware Law, to conclude that it must respond to such Superior
Proposal, then FHI and its officers, directors, employees, investment bankers,
attorneys, accountants and other representatives retained by it may furnish in
connection therewith information to the Person making such Superior Proposal and
engage in negotiations with such person, and such actions shall not be
considered a breach of this Section 5.3 or any other provisions of this
Agreement; provided that in each such event the Selling Shareholders and FHI
immediately notify Buyer of such determination by the FHI Board of Directors and
provides Buyer with a true and complete copy of the Superior Proposal received
from such third Person, and provides (or has provided) Buyer with all documents
containing or referring to nonpublic information of FHI supplied to such third
Person; provided further, that FHI shall provide such nonpublic information
pursuant to a nondisclosure agreement; and provided further, that the Selling
Shareholders and FHI shall not, and shall not permit any of its officers,
directors, employees or other representatives to, agree to or endorse any
Takeover Proposal unless the Selling Shareholders and FHI (i) have provided
Buyer at least five (5) days prior notice thereof, (ii) have terminated this
Agreement pursuant to Section 8.1(f), and (iii) have paid Buyer all amounts
payable pursuant to Section 8.3(b). The Selling Shareholders and FHI will
promptly notify Buyer after receipt of any Takeover

                                       35

<PAGE>

Proposal or any notice that any Person is considering making a Takeover Proposal
or any request for nonpublic information relating to FHI or any of its
Subsidiaries or for access to the properties, books or records of FHI or any of
its Subsidiaries by any Person that has advised FHI or any Selling Shareholder
that it may be considering making, or that has made, a Takeover Proposal, and
will keep Buyer fully informed of the status and details of any such Takeover
Proposal notice, and shall provide Buyer with a true and complete copy of such
Takeover Proposal notice or any amendment thereto, if in writing, or a complete
written summary thereof, if not in writing.

                                  ARTICLE VI -

                              ADDITIONAL AGREEMENTS

                  6.1      Access to Information.

                           (a)      FHI shall afford Buyer and its officers,
employees, accountants, counsel and other representatives access during normal
business hours during the period prior to the Effective Time to (i) all of FHI's
and its Subsidiaries' properties, books, contracts, commitments and records, and
(ii) all other information concerning the business, properties and personnel of
FHI and its Subsidiaries as Buyer may reasonably request. FHI shall provide to
Buyer and its accountants, counsel and other representatives, copies of internal
financial statements promptly upon request.

                           (b)      Subject to compliance with applicable law,
from the date hereof until the Effective Time, Davis and FHI shall confer on a
regular and frequent basis with one or more representatives of Buyer to report
operational matters of materiality and the general status of ongoing operations.

                           (c)      No information or knowledge obtained in any
investigation pursuant to this Section 6.1 shall affect or be deemed to modify
any representation or warranty contained herein or the conditions to the
obligations of the parties to consummate the transactions contemplated by this
Agreement, except as set forth in Section 5.1.

                  6.2      Public Disclosure. Unless otherwise permitted by this
Agreement, Buyer and FHI shall consult with each other before issuing any press
release or otherwise making any public statement or making any other public (or
non-confidential) disclosure (whether or not in response to an inquiry)
regarding the terms of this Agreement and the transactions contemplated hereby,
and neither shall issue any such press release or make any such statement or
disclosure without

                                       36

<PAGE>

the prior approval of the other (which approval shall not be unreasonably
withheld), except as may be required by law or as may be requested by A. M.
Best.

                  6.3      Consents; Cooperation.

                           (a)      Each of Buyer and FHI shall promptly apply
for or otherwise seek, and use its reasonable best efforts to obtain, all
consents and approvals required to be obtained by it for the consummation of the
transactions contemplated by this Agreement, and those required to be obtained
from the Pennsylvania Department of Insurance, and shall use reasonable best
efforts to obtain all necessary consents, waivers and approvals under any of the
material Contracts of FHI and its Subsidiaries in connection with the
transactions contemplated by this Agreement for the assignment thereof or
otherwise. The Parties will consult and cooperate with one another, and consider
in good faith the views of one another, in connection with any analyses,
appearances, presentations, memoranda, briefs, arguments, opinions and proposals
made or submitted by or on behalf of any Party in connection with proceedings
before any Insurance Authority. Buyer, with the cooperation of FHI, shall have
primary responsibility for attempting to obtain the consents referred to in
subsections 7.1 (b) and (g).

                           (b)      Each of Buyer and FHI shall use reasonable
best efforts to resolve such objections, if any, as may be asserted by any
Governmental Entity with respect to the transactions contemplated by this
Agreement under (i) any insurance holding company system act or insurance
company licensing act administered by any Insurance Authority and any rules or
regulations or policies thereunder, or (ii) any other federal, state or foreign
statutes, rules, regulations, orders or decrees designed to prohibit, restrict
or regulate actions having the purpose or effect of monopolization or restraint
of trade (collectively, "Antitrust Laws"). In connection therewith, if any
administrative or judicial action or proceeding is instituted (or threatened to
be instituted) challenging any transaction contemplated by this Agreement as
prohibited by any law administered by an Insurance Authority or as violating any
Antitrust Law, each of Buyer and FHI shall cooperate and use reasonable best
efforts vigorously to contest and resist any such action or proceeding and to
have vacated, lifted, reversed, or overturned any decree, judgment, injunction
or other order, whether temporary, preliminary or permanent (each an "Order"),
that is in effect and prohibits, prevents or restricts consummation of the
transactions contemplated by this Agreement or any such other transactions,
unless Buyer and FHI mutually decide in good faith that litigation is not in
their respective best interests. Notwithstanding the immediately preceding
sentence, it is expressly understood and agreed that no Party shall have any
obligation to litigate or contest any administrative or judicial action or
proceeding or any Order beyond December 31, 2001. Buyer and FHI also shall

                                       37

<PAGE>

take any and all of the following actions to the extent reasonably necessary to
obtain the approval of any Insurance Authority or other Governmental Entity with
jurisdiction over the enforcement of any applicable laws regarding the
transactions contemplated hereby: entering into negotiations; providing
information required by law or governmental regulation; and substantially
complying with any second request for information pursuant thereto.
Notwithstanding anything to the contrary in this Section 6.3, neither Buyer nor
FHI nor any of its Subsidiaries shall be required to take any action that would
reasonably be expected to substantially impair the overall benefits expected, as
of the date hereof, to be realized from the consummation of the transactions
contemplated hereby.

                           (c)      Notwithstanding anything to the contrary in
Section 6.3(a) or (b), (i) neither Buyer nor any of its Subsidiaries shall be
required to divest any of their respective businesses, services, product lines,
assets, or to take or agree to take any other action or agree to any limitation
that would reasonably be expected to have a Material Adverse Effect on Buyer
after the Effective Time, and (ii) neither FHI nor its Subsidiaries shall be
required to divest any of their respective businesses, services, product lines
or assets, or to take or agree to take any other action or agree to any
limitation that would reasonably be expected to have a Material Adverse Effect
on FHI.

                  6.4      Legal Requirements. Each of Buyer, and FHI shall, and
shall cause their respective Affiliates to, take all reasonable actions
necessary to comply promptly with all legal requirements that may be imposed on
any of them with respect to the consummation of the transactions contemplated by
this Agreement, shall promptly cooperate with and furnish information to any
Party necessary in connection with any such requirements imposed upon such other
Party in connection with the consummation of such transactions, and shall take
all reasonable actions necessary to obtain (and cooperate with the other Parties
in obtaining) any consent, approval, order or authorization of, or any
registration, declaration or filing with, any Governmental Entity or other
Person, required to be obtained or made in connection with the taking of any
action contemplated by this Agreement.

                  6.5      Best Efforts and Further Assurances. Each of the
Parties shall use reasonable best efforts to effectuate the transactions
contemplated hereby and to fulfill and cause to be fulfilled the conditions to
Closing hereunder. Each Party, at the reasonable request of another Party, shall
execute and deliver such other instruments and do and perform such other acts
and things as may be necessary or desirable for effecting completely the
consummation of the transactions contemplated hereby.

                                 ARTICLE VII -

                                       38

<PAGE>

                                   CONDITIONS

                  7.1      Conditions to Obligations of Each Party. The
respective obligations of each Party to consummate and effect this Agreement and
the transactions contemplated hereby shall be subject to satisfaction at or
prior to the Effective Time of the following conditions, any of which may be
waived, in writing, by agreement of all Parties:

                           (a)      No Injunctions or Restraints; Illegality. No
temporary restraining order, preliminary or permanent injunction or other order
issued by any Governmental Entity or other legal or regulatory restraint or
prohibition preventing the consummation of the transactions contemplated by this
Agreement shall be in effect, nor shall any proceeding brought by a Governmental
Entity seeking any of the foregoing be pending; nor shall there be any action
taken, or any statute, rule, regulation or order enacted, entered, enforced or
deemed applicable to the transactions contemplated by this Agreement, that makes
the consummation of the transactions contemplated by this Agreement illegal or
impractical. In the event an injunction or other order shall have been issued,
each Party shall use commercially reasonable efforts to have such injunction or
other order lifted.

                           (b)      Governmental Approvals. The Parties and
their respective Subsidiaries and Affiliates shall have timely filed with and
obtained from each Governmental Entity (including all Insurance Authorities) all
filings, notices, approvals, waivers and consents necessary for consummation of
the transactions contemplated by this Agreement and the transactions
contemplated hereby, including such filings, notices, approvals, waivers and
consents as may be required under applicable state insurance laws.

                           (c)      Injunctions or Restraints on Conduct of
Business. No temporary restraining order, preliminary or permanent injunction or
other order issued by any Governmental Entity or other legal or regulatory
restraint provision limiting or restricting Buyer's conduct or operation of the
business of FHI and its Subsidiaries following the transactions contemplated by
this Agreement shall be in effect, nor shall any proceeding brought by any
Governmental Entity seeking the foregoing be pending or threatened in writing.

                           (d)      Shareholder Agreement. Davis, FHI and Buyer
shall have executed the Shareholder Agreement attached hereto as Exhibit A.

                           (e)      Agency Business Agreement. Davis and Buyer
shall have executed the Agency Business Agreement attached hereto as Exhibit B.

                                       39

<PAGE>

                           (f)      Employment Agreement. Davis and Buyer shall
have executed the Employment Agreement attached hereto as Exhibit C.

                           (g)      Consent and Waiver of Preferred Holders. The
Parties shall have received evidence reasonably satisfactory to them that: (i)
each of the Series A Holders and American Reinsurance Company, as the holder of
the Series B Preferred Stock, shall have executed a unanimous written consent to
the transactions contemplated hereby and the filing of the Third Amended and
Restated Certificate of Incorporation of FHI attached hereto as Exhibit D; (ii)
the Series A Holders shall have executed and delivered the Series A Stock
Purchase Agreement and the closing thereunder shall occur simultaneously with
the Closing under this Agreement; (iii) American Reinsurance Company shall have
agreed to terminate the Internal Shareholder Agreement dated December 30, 1997
between American Reinsurance Company and Davis; and (iv) American Reinsurance
Company shall have delivered to FHI for cancellation the Class B Non-Voting
Common Stock Purchase Warrant dated December 30, 1997 that gives the holder the
right to acquire 100,000 shares of Class B Stock.

                  7.2      Additional Conditions to Obligations of Davis. The
obligations of Davis to consummate and effect this Agreement and the
transactions contemplated hereby shall be subject to the satisfaction at or
prior to the Effective Time of the following conditions, any of which may be
waived, in writing, by Davis

                           (a)      Representations, Warranties and Covenants.
(i) The representations and warranties of Buyer in this Agreement shall be true
and correct in all material respects (except for such representations and
warranties that are qualified by their terms by a reference to materiality,
which representations and warranties as so qualified shall be true in all
respects) on and as of the date hereof and the Effective Time as though such
representations and warranties were made on and as of such times, and (ii) Buyer
shall have performed and complied in all material respects with all covenants,
obligations and conditions of this Agreement required to be performed and
complied with by Buyer as of the Effective Time.

                           (b)      Certificate of Buyer. Davis and FHI shall
have received a certificate executed on behalf of Buyer by its President
certifying that the condition set forth in Section 7.2(a) shall have been
fulfilled.

                           (c)      Appointment of Davis. The Board of Directors
of Buyer shall have appointed Davis to its Board of Directors and the Board of
Directors of each of its Subsidiaries.

                                       40

<PAGE>

                           (d)      No Material Adverse Changes. There shall not
have occurred any event which could cause a Material Adverse Effect on Buyer.

                  7.3      Additional Conditions to the Obligations of Buyer.
The obligations of Buyer to consummate and effect this Agreement and the
transactions contemplated hereby shall be subject to the satisfaction at or
prior to the Effective Time of the following conditions, any of which may be
waived, in writing, by Buyer:

                           (a)      Representations, Warranties and Covenants.
(i) The representations and warranties of Davis and FHI in this Agreement shall
be true and correct in all material respects (except for such representations
and warranties that are qualified by their terms by a reference to materiality,
which representations and warranties as so qualified shall be true in all
respects) on and as of the date hereof and the Effective Time as though such
representations and warranties were made on and as of such times, and (ii) Davis
and FHI shall have performed and complied in all material respects with all
covenants, obligations and conditions of this Agreement required to be performed
and complied with by them as of the Effective Time.

                           (b)      Certificate of FHI. Buyer shall have been
provided with a certificate executed by Davis individually, and on behalf of FHI
as its President, certifying that the condition set forth in Section 7.3(a)
shall have been fulfilled.

                           (c)      Third Party Consents. FHI shall have
obtained, and Buyer shall have been furnished with evidence reasonably
satisfactory to it, of the consent or approval of those Persons whose consent or
approval shall be required in connection with the transactions contemplated by
this Agreement under any material Contract of FHI or any of its Subsidiaries or
otherwise, except where failure to obtain such consent would not have a Material
Adverse Effect on FHI.

                           (d)      No Material Adverse Changes. There shall not
have occurred any event which could cause a Material Adverse Effect on FHI.

                           (e)      Options. With the written consent of Davis,
FHI shall have canceled all outstanding options to acquire Class A Stock and
issued to Davis in their place the Options.

                           (f)      Resignation and Election of FHI Directors.
Each member of the Board of Directors of FHI and its Subsidiaries, other than
Davis, shall have tendered his or her resignation effective as of the Effective
Time and the existing directors of Buyer shall be elected or appointed directors
of FHI and each of its Subsidiaries.

                                       41

<PAGE>

                                 ARTICLE VIII -

                        TERMINATION, AMENDMENT AND WAIVER

                  8.1      Termination. At any time prior to the Effective Time
this Agreement may be terminated:

                           (a)      by mutual consent of Buyer and Davis;

                           (b)      by Buyer or Davis, if, without fault of the
terminating Party, the Closing shall not have occurred on or before September
30, 2001 (provided a later date may be agreed upon in writing by the Parties,
and provided further that the right to terminate this Agreement under this
Section 8.1(b) shall not be available to any Party whose action or failure to
act has been the cause of or resulted in the failure of the transactions
contemplated by this Agreement to occur on or before such date and such action
or failure to act constitutes a breach of this Agreement);

                           (c)      by Buyer, if the Selling Shareholders or FHI
shall materially breach any of their representations, warranties or obligations
hereunder or under the Series A Stock Purchase Agreement and such breach shall
not have been cured within fifteen (15) business days of receipt by the Selling
Shareholders and FHI of written notice of such breach, or if such breach cannot
be cured within such time period but can be cured prior to the Effective Time
and the Selling Shareholder or FHI, as the case may be, has not commenced
actions reasonably necessary (in the opinion of Buyer) to cure such breach.

                           (d)      by Davis, if Buyer shall materially breach
any of its representations, warranties or obligations hereunder and such breach
shall not have been cured within fifteen (15) business days following receipt by
Buyer of written notice of such breach, or if such breach cannot be cured by
Buyer within such time period but can be cured by Buyer prior to the Effective
Time and Buyer has not commenced actions reasonably necessary (in the opinion of
FHI) to cure such breach;

                           (e)      by Buyer if a Takeover Proposal shall have
occurred and FHI's Board of Directors does not within ten (10) business days of
such occurrence (i) reconfirm its approval of this Agreement and the
transactions contemplated hereby, and (ii) reject such Takeover Proposal;

                           (f)      by Davis and FHI if a Superior Proposal
shall have been received; provided that FHI shall have provided Buyer at least
five (5) business days prior notice of the terms of the Superior Proposal and
FHI shall have paid Buyer the amounts set forth in Section 8.3(b); or

                                       42

<PAGE>

                           (g)      by any Party if any permanent injunction or
other order of a Governmental Entity preventing the consummation of the
transactions contemplated by this Agreement shall have become final and
non-appealable.

                  8.2      Effect of Termination. In the event of termination of
this Agreement as provided in Section 8.1, this Agreement shall forthwith become
void and there shall be no liability or obligation on the part of Buyer, the
Selling Shareholders or FHI or their respective officers, directors,
shareholders or affiliates, except to the extent that such termination results
from the breach by a Party of any of its representations, warranties or
covenants in this Agreement; provided that the provisions of Section 8.3,
Article X, and this Section 8.2 shall remain in full force and effect and
survive any termination of this Agreement. Section 8.3 sets forth the exclusive
remedy in the event of a termination.

                  8.3      Expenses and Termination Fees.

                           (a)      Subject to subsections (b), (c), (d) and (e)
of this Section 8.3, whether or not the transactions contemplated by this
Agreement is consummated, all costs and expenses incurred in connection with
this Agreement and the transactions contemplated hereby (including the fees and
expenses of its advisers, accountants and legal counsel) shall be paid by the
Party incurring such expense.

                           (b)      In the event (i) Buyer terminates this
Agreement pursuant to Section 8.1(e) or FHI terminates this Agreement pursuant
to Section 8.1(f), or (ii) Buyer terminates this Agreement pursuant to Section
8.1(c) due in whole or in part to any failure by the Selling Shareholders or FHI
to use its or their reasonable best efforts to perform and comply with all
agreements and conditions required by this Agreement to be performed or complied
with by the Selling Shareholders or FHI prior to or on the Closing Date or any
failure by the Selling Shareholders' or FHI's Affiliates to take any actions
required to be taken hereby, and prior thereto there shall have been a Takeover
Proposal with respect to FHI that shall not have been rejected by Davis and FHI,
then Davis and FHI jointly and severally shall reimburse Buyer for all of the
out-of-pocket costs and expenses, up to an aggregate of $50,000, incurred by
Buyer in connection with this Agreement and the transactions contemplated hereby
(including the fees and expenses of its financial advisors, accountants and
outside legal counsel), and, in addition to any other remedies Buyer may have,
Davis and FHI jointly and severally shall pay to Buyer the sum of $250,000 no
later than two (2) business days thereafter.

                           (c)      In the event that (i) Buyer terminates this
Agreement pursuant to Section 8.1(c) as a result of a breach by FHI or Davis and
under circumstances not described in Section 8.3(b)(ii), Davis and FHI, jointly
and

                                       43

<PAGE>

severally, shall promptly reimburse Buyer for all out-of-pocket costs and
expenses, up to an aggregate of $50,000 incurred by Buyer in connection with
this Agreement and the transactions contemplated hereby (including the fees and
expenses of its financial advisors, accountants and outside legal counsel); and,
in the event (A) any Takeover Proposal is consummated (as defined in Section
8.3(f)) by or with any Person that made a Takeover Proposal prior to termination
of this Agreement or any Affiliate of any such Person, within twelve months of
the later of, or (B) any other Takeover Proposal not described in clause (A) is
consummated (as defined in Section 8.3(f)) within six months of the later of,
(x) such termination of this Agreement, and (y) the payment of the above
described expenses, Davis and FHI, jointly and severally shall pay to Buyer the
additional sum of $250,000 (less any amounts paid by FHI to Buyer under Section
8.3(b)) no later than two (2) business days thereafter.

                           (d)      In the event Davis terminates this Agreement
pursuant to Section 8.1(d), Buyer shall promptly reimburse FHI for all of the
out-of-pocket costs and expenses, up to an aggregate of $50,000, incurred by FHI
in connection with this Agreement and the transactions contemplated hereby
(including the fees and expenses of its financial advisors, accountants and
outside legal counsel).

                           (e)      As used herein, "Takeover Proposal" means
any offer or proposal for, or any indication of interest in, a merger or other
business combination involving FHI or any of its Subsidiaries or the acquisition
of 20% or more of the outstanding shares of capital stock of FHI, or a
significant portion of the assets of, FHI or any of its Subsidiaries, other than
the transactions contemplated by this Agreement.

                           (f)      For purposes of Section 8.3(c),
"consummation" of a Takeover Proposal shall occur on the date a written
agreement is entered into with respect to a merger or other business combination
involving FHI or the acquisition of 20% or more of the outstanding shares of
capital stock of FHI, or sale or transfer of any material assets (excluding the
sale or disposition of assets in the ordinary course of business) of FHI or any
of its Subsidiaries.

                  8.4      Amendment. The Parties may amend this Agreement at
any time by execution of an instrument in writing signed on behalf of each of
the Parties.

                  8.5      Extension; Waiver. At any time prior to the Effective
Time any Party may, to the extent legally allowed, (i) extend the time for the
performance of any of the obligations or other acts of the other Parties, (ii)
waive any inaccuracies in the representations and warranties made to such Party
contained herein or in any document delivered pursuant hereto, and (iii) waive
compliance with any of the

                                       44

<PAGE>

agreements or conditions for the benefit of such Party contained herein. Any
agreement on the part of a Party to any such extension or waiver shall be valid
only if set forth in an instrument in writing signed on behalf of such Party.

                                  ARTICLE IX -

                                 INDEMNIFICATION

                  9.1      Indemnification By FHI and Davis. Subject to the
terms and conditions of this Section 9.1, which shall become effective upon
Closing, FHI and Davis shall indemnify, defend and hold harmless Buyer, from,
against and with respect to any claim, liability, obligation, loss, damage,
deficiency, assessment, encumbrance, judgment, cost, expense (including, without
limitation, attorney fees and costs and expenses incurred in investigating,
preparing, defending against or prosecuting any litigation or claim, action,
suit, proceeding or demand), of any kind or character, arising out of or in any
manner incident, relating or attributable to (i) any inaccuracy in any
representation or any breach or failure of any warranty, covenant or agreement
of FHI and Davis set forth in this Agreement or the Schedules attached hereto,
or in any certificate, instrument of transfer or other document or agreement
executed by FHI or Davis in connection with this Agreement, or otherwise made or
given in connection with this Agreement, or (ii) any failure by FHI or Davis to
perform or observe, or to have performed or observed, in full any covenant,
agreement or condition to be performed or observed by FHI or Davis under this
Agreement or under any certificates or other documents or agreements executed by
FHI or Davis in connection with this Agreement. The matters specified in clauses
(i) and (ii) above are hereinafter referred to as "Indemnifiable Claims".

                  9.2      Indemnification By Buyer. Subject to the terms and
conditions of this Section 9.2, Buyer shall indemnify, defend and hold harmless
FHI and Davis from, against and with respect to any claim, liability,
obligation, loss, damage, deficiency, assessment, encumbrance, judgment, cost,
expense (including, without limitation, attorneys' fees and costs and expenses
incurred in investigating, preparing, defending against or prosecuting any
litigation or claim, action, suit, proceeding or demand), of any kind or
character, arising out of or in any manner incident, relating or attributable to
(i) any inaccuracy in any representation or any breach or failure of any
warranty, covenant or agreement of Buyer set forth in this Agreement or in any
certificate, other document or agreement executed by Buyer in connection with
this Agreement or otherwise made or given in connection with this Agreement, and
(ii) any failure by Buyer to perform or observe, or to have performed or
observed, in full any covenant, agreement or condition to be performed or
observed by Buyer under this Agreement or under any certificate or

                                       45

<PAGE>

other documents or agreement executed by Buyer in connection with this
Agreement.

                  9.3      Limitation of Indemnification Obligation. Section 9.1
shall be the exclusive remedy of Buyer against Davis in regard to any
Indemnifiable Claim. Furthermore, Davis shall have no obligation with respect to
any Indemnifiable Claim to the extent:

                           (a)      such claim for indemnity does not exceed
Seventy-Five Thousand Dollars ($75,000) and if all such claims exceed
Seventy-Five Thousand Dollars ($75,000) in the aggregate, Davis shall be liable
for amounts in excess of Seventy-Five Thousand Dollars ($75,000), subject to the
other limitations set forth in this Article IX;

                           (b)      such claim for indemnity exceeds, or all
claims for indemnity (inclusive of such claim) exceed, subject to the other
limitations set forth in this Article IX, the purchase price paid to Davis under
this Agreement, unless the claim results from a Fraudulent Breach by Davis or
FHI, in which case such limit shall not apply;

                           (c)      the loss, event, liability or matter giving
rise thereto is covered by insurance or reinsurance proceeds or other salvage
reasonably recoverable or actually received by Buyer or FHI on account of the
event that gave rise to the claim;

                           (d)      the event, liability or matter giving rise
thereto provides the Buyer or FHI with any tax benefit; or

                           (e)      the claim is for other than direct
compensatory damages, unless the claim arises from a third party asserting
another form of damages.

                  9.4      Time Limits for Claims against Davis. Davis shall
have no obligation with respect to any Indemnifiable Claim unless Buyer provides
to Davis a written notice setting forth with reasonable specificity the facts of
the Indemnifiable Claim within the later of:

                           (a)      One year after the Closing Date;

                           (b)      if the basis for such claim arises from a
breach of any representation, warranty or covenant relating to Taxes, in which
event the claim may be asserted at any time within the applicable statute of
limitations; or

                           (c)      if the basis for such claim arises from a
Fraudulent Breach by Davis or FHI, there shall be no limit, except that the
notice of the claim

                                       46

<PAGE>

must be provided within six (6) months after the basis for such claim of
Fraudulent Breach becomes known to Buyer.

                  9.5      Additional Limitation of Indemnification Obligation
of Davis. In the event that Davis shall become obligated to provide
indemnification under Section 9.1 the liability of Davis shall not exceed the
product of: (i) the amount of any such liability as determined after application
of the limitations set forth in Section 9.3, and (ii) 0.71.

                                   ARTICLE X -

                               GENERAL PROVISIONS

                  10.1     Survival Past Effective Time. The representations,
warranties, covenants and agreements set forth in this Agreement shall survive
the Effective Time, subject to the time limitations set forth in Section 9.4.

                  10.2     Notices. All notices and other communications
hereunder shall be in writing and shall be deemed given if delivered personally
or by commercial delivery service, or mailed by registered or certified mail
(return receipt requested) or sent via facsimile (with confirmation of receipt)
to the parties at the following address (or at such other address for a party as
shall be specified by like notice):

         if to Buyer to:

         Mercer Mutual Insurance Company
         Route 31 North
         Pennington, New Jersey
         Attention: Andrew R. Speaker,
         President and Chief
         Executive Officer
         Facsimile No.: 609-737-8719
         Telephone No.: 609-737-0426

         with a copy to:

         Stevens & Lee
         1275 Drummers Lane
         P. O. Box 236
         Wayne, PA 19087-0236
         Attention: Jeffrey P. Waldron
         Facsimile No.: 610-687-1384
         Telephone No.: 610-293-4961

                                       47

<PAGE>

         to FHI or the Selling Shareholders, to:

         Franklin Holding Company, Inc.
         214 East Church Street
         Lock Haven, Pennsylvania 17745
         Facsimile No. 717-570-6655
         Telephone No. 717-570-3234

         with a copy to:

         Rosenn, Jenkins & Greenwald, LLP
         15 South Franklin Street
         Wilkes-Barre, Pennsylvania 18711
         Attention: Bruce C. Rosenthal, Esquire
         Facsimile No.: 570-821-4714
         Telephone No.: 570-826-5643

                  10.3     Counterparts. This Agreement may be executed in one
or more counterparts, all of which shall be considered one and the same
agreement and shall become effective when one or more counterparts have been
signed by each of the Parties and delivered to the other Parties, it being
understood that all Parties need not sign the same counterpart.

                  10.4     Entire Agreement; Nonassignability; Parties in
Interest. This Agreement and the documents and instruments and other agreements
specifically referred to herein or delivered pursuant hereto, including the
Exhibits, and the FHI Disclosure Schedule (a) constitute the entire agreement
among the Parties with respect to the subject matter hereof and supersede all
prior agreements and understandings, both written and oral, among the Parties
with respect to the subject matter hereof, and shall survive any termination of
this Agreement or the Closing, in accordance with its terms; (b) are not
intended to confer upon any other Person any rights or remedies hereunder; and
(c) shall not be assigned by operation of law or otherwise, except that Buyer
may assign its rights under this Agreement to any of its Subsidiaries, provided
that if such assignee Subsidiary fails to perform any obligation hereunder,
Buyer shall remain liable for full performance thereof.

                  10.5     Severability. In the event any provision of this
Agreement or the application thereof becomes or is declared by a court of
competent jurisdiction to be illegal, void or unenforceable, the remainder of
this Agreement will continue in full force and effect and the application of
such provision to other Persons or circumstances will be interpreted so as
reasonably to effect the intent of the Parties. The Parties further agree to
replace such void or unenforceable provision of this Agreement with a valid and
enforceable provision that will achieve, to the extent

                                       48

<PAGE>

possible, the economic, business and other purposes of such void or
unenforceable provision.

                  10.6     Remedies Cumulative. Except as otherwise provided
herein, any and all remedies herein expressly conferred upon a Party will be
deemed cumulative with and not exclusive of any other remedy conferred hereby,
or by law or equity upon such Party, and the exercise by a Party of any one
remedy will not preclude the exercise of any other remedy.

                  10.7     Governing Law. This Agreement shall be governed by
and construed in accordance with the laws of the Commonwealth of Pennsylvania.

                  10.8     Rules of Construction. The Parties have been
represented by counsel during the negotiation, preparation and execution of this
Agreement and, therefore, waive the application of any law, regulation, holding
or rule of construction providing that ambiguities in an agreement or other
document will be construed against the Party drafting such agreement or
document.

         IN WITNESS WHEREOF, FHI, Buyer and Davis have caused this Agreement to
be executed and delivered as of the date first written above.

                                                 FRANKLIN HOLDING COMPANY, INC.

                                                 By: /s/ H. Thomas Davis
                                                    ____________________________
                                                    Name: H. Thomas Davis
                                                    Title: President and Chief
                                                    Executive Officer

                                                 MERCER MUTUAL INSURANCE COMPANY

                                                 By: /s/ Andrew R. Speaker
                                                    ____________________________
                                                    Name: Andrew R. Speaker
                                                    Title: President and Chief
                                                    Executive Officer

                                                 /s/ H. Thomas Davis
                                                 _______________________________
                                                 H. Thomas Davis, individually

                                       49<PAGE>
                                                                    EXHIBIT 10.9

                            STOCK PURCHASE AGREEMENT

                                  BY AND AMONG

                         MERCER MUTUAL INSURANCE COMPANY

                                       AND

     ANTHONY ROBERT SCATENA, RAYMOND EDWARD NESTLERODE, SR., RAYMOND EDWARD
  NESTLERODE, JR., JOSEPH RUSSELL NESTLERODE, SR., WILLIAM J. EDWARDS, MICHAEL
                                 PETER NESTARICK

                            DATED AS OF MAY 9, 2001

<PAGE>

                                Table of Contents

<TABLE>
<CAPTION>
                                                                                                                    Page
                                                                                                                    ----
<S>                                                                                                                 <C>
ARTICLE I   -  DEFINITIONS...................................................................................         2
         1.1  Construction...................................................................................         2
         1.2  Definitions....................................................................................         2

ARTICLE II  -  PURCHASE AND SALE OF STOCK....................................................................         5
         2.1  Purchase and Sale of Series A Preferred Stock..................................................         5
         2.2  Closing; Closing Date..........................................................................         5
         2.3  Closing Deliveries.............................................................................         5

ARTICLE III -  REPRESENTATIONS AND WARRANTIES................................................................         6
         3.1  Ownership of Series A Preferred Stock..........................................................         6
         3.2  Authority......................................................................................         6
         3.3  Representations Complete.......................................................................         7

ARTICLE IV  -  REPRESENTATIONS AND WARRANTIES OF BUYER.......................................................         7
         4.1  Organization, Standing and Power...............................................................         7
         4.2  Authority......................................................................................         7
         4.3  Litigation.....................................................................................         8
         4.4  Broker's and Finders' Fees.....................................................................         8
         4.5  Board Approval.................................................................................         8
         4.6  Financial Capability...........................................................................         8
         4.7  Representations Complete.......................................................................         9

ARTICLE V   -  CONDUCT PRIOR TO THE EFFECTIVE TIME...........................................................         9
         5.1  No Solicitation................................................................................         9
         5.2  Consents; Cooperation..........................................................................         9
         5.3  Legal Requirements.............................................................................        10
         5.4  Best Efforts and Further Assurances............................................................        10

ARTICLE VI  -  CONDITIONS 10
         6.1  Conditions to Obligations of Each Party........................................................        10
         6.2  Additional Conditions to Obligations of the Series A Holders...................................        11
         6.3  Additional Conditions to the Obligations of Buyer..............................................        11

ARTICLE VII -  TERMINATION, AMENDMENT AND WAIVER.............................................................        12
         7.1  Termination....................................................................................        12
</TABLE>

                                        i

<PAGE>

                                Table of Contents
                                  (continued)

<TABLE>
<CAPTION>
                                                                                                                    Page
                                                                                                                    ----
<S>                                                                                                                 <C>
         7.2  Effect of Termination..........................................................................        13
         7.3  Expenses and Termination Fees. Whether or not the transactions contemplated by this
              Agreement is consummated, all costs and expenses incurred in connection with this
              Agreement and the transactions contemplated hereby (including the fees and expenses of
              its advisers, accountants and legal counsel) shall be paid by the Party incurring such
              expense........................................................................................        14
         7.4  Amendment......................................................................................        14
         7.5  Extension; Waiver..............................................................................        14

ARTICLE VIII-  INDEMNIFICATION...............................................................................        14
         8.1  Indemnification By Series A Holders............................................................        14
         8.2  Indemnification By Buyer.......................................................................        15
         8.3  Limitation of Indemnification Obligation.......................................................        16
         8.4  Additional Limitation of Indemnification Obligation of Series A Holders........................        16

ARTICLE IX  -  GENERAL PROVISIONS............................................................................        17
         9.1  Survival Past Effective Time...................................................................        17
         9.2  Notices........................................................................................        17
         9.3  Counterparts...................................................................................        18
         9.4  Entire Agreement; Nonassignability; Parties in Interest........................................        18
         9.5  Severability...................................................................................        18
         9.6  Remedies Cumulative............................................................................        18
         9.7  Governing Law..................................................................................        19
         9.8  Rules of Construction..........................................................................        19
</TABLE>

                                       ii

<PAGE>

EXHIBIT A - Third Amended and Restated Certificate of Incorporation of FHI

<PAGE>

                            STOCK PURCHASE AGREEMENT

         This STOCK PURCHASE AGREEMENT(this "Agreement") is made and entered
into as of May 9, 2001, by and among MERCER MUTUAL INSURANCE COMPANY, a
Pennsylvania corporation ("Buyer"), and ANTHONY ROBERT SCATENA, RAYMOND EDWARD
NESTLERODE, SR., RAYMOND EDWARD NESTLERODE, JR., JOSEPH RUSSELL NESTLERODE, SR.,
WILLIAM J. EDWARDS, and MICHAEL PETER NESTARICK, collectively the holders of all
the Series A Preferred Stock (the "Series A Holders") issued by Franklin Holding
Company, Inc. ("FHI"). Buyer and the Series A Holders are sometimes collectively
referred to herein as the "Parties" and individually as a "Party."

                                    RECITALS

         H. Thomas Davis ("Davis") owns (i) 210,000 shares of FHI Class A Voting
Common Stock (the "Class A Stock"), and (ii) and options to acquire 590,000
shares of Class A Stock (the "Options").

         The Series A Holders own 10,000 shares of FHI Series A Convertible
Redeemable Preferred Stock (the "Series A Preferred Stock").

         On or prior to the date of closing contemplated hereunder, Davis will
exchange the options to acquire 590,000 shares of Class A Stock for options (as
so exchanged, the "Options") to acquire 590,000 shares of Class B Non-Voting
Common Stock (the "Class B Stock")

         Davis has agreed to sell to Buyer, and Buyer has agreed to purchase
from Davis, 102,900 shares of Class A Stock and Options to acquire 295,000
shares of Class B Stock.

         The Series A Holders have agreed to sell to the Buyer, and the Buyer
has agreed to purchase from the Series A Holders, 5,000 shares of Series A
Preferred Stock.

         NOW, THEREFORE, in consideration of the covenants and representations
set forth herein, and for other good and valuable consideration, the Parties
agree as follows:

                                       1

<PAGE>

                                  ARTICLE I -

                                  DEFINITIONS

                  1.1      Construction. References to any federal, state, local
or foreign statute or law shall be deemed also to refer to all rules and
regulations promulgated thereunder, unless the context requires otherwise.
Unless the context otherwise requires, all references to "Sections," "Exhibits"
and "Schedules" shall be deemed to refer to Sections within or Exhibits and
Schedules to this Agreement. All Exhibits and Schedules to this Agreement are
hereby incorporated herein. The word "including" shall mean including without
limitation. Unless the context otherwise requires, any word used in the singular
form shall be interpreted as including the plural form thereof, and vice versa,
and any word used in one gender shall be interpreted as including the other
gender, as necessary or appropriate. Any reference to facts or information
"known" to a Party that is an entity, or words having similar meaning, shall
refer to the conscious awareness of information of the directors and those
responsible officers and employees of such Party and its Subsidiaries charged
with administrative or operational responsibility for such matters, and that is
known or would be known to any one or more of them following reasonable
investigation under the circumstances.

                  1.2      Definitions. Certain capitalized terms used in this
Agreement shall have the meanings ascribed to such terms in this Section 1.2,
unless the context clearly requires otherwise.

                           (a)      "Buyer" shall mean Mercer Mutual Insurance
Company, a Pennsylvania corporation.

                           (b)      "Agreement" shall mean this Stock Purchase
Agreement.

                           (c)      "Class A Stock" means the Class A Voting
Common Stock, $0.10 par value per share, of FHI.

                           (d)      "Class B Stock" means the Class B Non-Voting
Stock, $0.10 par value per share, of FHI.

                           (e)      "Closing" shall have the meaning set forth
in Section 2.2.

                           (f)      "Closing Date" shall have the meaning set
forth in Section 2.2.

                                       2

<PAGE>

                           (g)      "Contract" or "Contracts" means any
mortgage, indenture, lease, note, contract or other agreement or instrument to
which a Person is a party or by which such Person or such Person's assets are or
may be bound.

                           (h)      "Davis" means H. Thomas Davis, an
individual, and his heirs, personal representatives and assigns.

                           (i)      "Davis Stock Purchase Agreement" means the
Stock Purchase Agreement among, Davis, FHI and Buyer pursuant to which Buyer
will acquire a portion of Davis' stock in FHI.

                           (j)      "Effective Time" shall have the meaning set
forth in Section 2.2.

                           (k)      "FHI" shall mean Franklin Holding Company,
Inc., a Delaware corporation.

                           (l)      "FHI Capital Stock" means the Class A Stock,
the Class B Stock, the Series A Preferred Stock and the Series B Preferred
Stock.

                           (m)      "Governmental Entity" means any court,
administrative agency or commission or other governmental or regulatory agency,
authority or instrumentality of any federal, state, local or foreign government,
of any kind, type or nature.

                           (n)      "Liens" shall have the meaning set forth in
Section 3.1.

                           (o)      "Material Adverse Effect" with respect to
any Person means any event, change, condition or effect, including consummation
of the transactions contemplated by this Agreement, that (i) has, or could
reasonably be expected to have, a materially adverse effect on the condition
(financial or otherwise), properties, assets, liabilities, business, operations
or results of operations of such Person and its Subsidiaries, taken as a whole
(whether or not arising from transactions in the ordinary course of business)
(excluding changes in security portfolio values due to changes in interest rates
or changes in statutory or generally accepted accounting principles that affect
the insurance industry as a whole), (ii) materially impairs, or could reasonably
be expected to materially impair, the ability of such Person to perform its
obligations under this Agreement or any related agreement or to consummate the
transactions contemplated by this Agreement, or (iii) causes A. M. Best, either
orally or in writing, to advise such Person that it's A. M. Best rating will be,
or is likely to be, reduced.

                           (p)      "Options" means the options to acquire
590,000 shares of Class B Stock.

                                       3

<PAGE>

                           (q)      "Parties" shall mean Buyer and the Series A
Holders, collectively.

                           (r)      "Party" shall mean Buyer and any one of the
Series A Holders, individually.

                           (s)      "Person" means any natural person or
individual, trustee, corporation, general or limited partnership, limited
liability company or partnership, joint venture, joint stock company, bank,
firm, Governmental Entity, trust, association, organization or unincorporated
entity of any kind.

                           (t)      "Series A Holders" means Anthony Robert
Scatena, Raymond Edward Nestlerode, Sr., Raymond Edward Nestlerode, Jr., Joseph
Russell Nestlerode, Sr., William J. Edwards, Michael Peter Nestarick and their
respective heirs, personal representatives and assigns.

                           (u)      "Series A Preferred Stock" means the Series
A Convertible Redeemable Preferred Stock, $100 par value per share, of FHI.

                           (v)      "Series B Preferred Stock" means the Series
B Cumulative Redeemable Preferred Stock, $100 par value per share, of FHI.

                           (w)      "Shareholder Documents" means the following
documents and instruments, copies of which have been furnished to the Buyer:
Certificate of Incorporation and By-laws of FHI, the Subscription and
Shareholders Agreement among Davis, FHI and the Series A Holders, the Securities
Purchase Agreement between FHI and the Series B Holder, the Class B Non-voting
Common Stock Purchase Warrant issued by FHI to the Series B Holder, and the
Internal Shareholders Agreement between Davis and the Series B Holder.

                           (x)      "Subsidiary" or "Subsidiaries" shall mean,
with respect to any Party (other than an individual), any corporation, limited
liability company, partnership, trust, limited partnership, joint venture, or
other business association or entity, at least a majority of the voting
securities or economic interests of which is directly or indirectly owned or
controlled by such Party or by any one or more of its Subsidiaries.

                           (y)      "Takeover Proposal" shall have the meaning
set forth in Section 5.1.

                                       4

<PAGE>

                                  ARTICLE II -

                           PURCHASE AND SALE OF STOCK

                  2.1      Purchase and Sale of Series A Preferred Stock.
Subject to the terms and conditions of this Agreement, on the Closing Date, each
Series A Holder shall sell to Buyer, and Buyer shall purchase from each Series A
Holder, that number of shares of Series A Preferred Stock set forth opposite the
name of the Series A Holder as follows:

<TABLE>
<S>                                         <C>
Anthony Robert Scatena                      2,500 shares
Raymond Edward Nestlerode, Sr.                500 shares
Raymond Edward Nestlerode, Jr.                500 shares
Joseph Russell Nestlerode, Sr.                500 shares
William J. Edwards                            500 shares
Michael Peter Nestarick                       500 shares
</TABLE>

The purchase price for the Series A Preferred Stock shall be $200 per share, or
$1,000,000 in the aggregate.

                  2.2      Closing; Closing Date. The Closing shall take place
at the offices of Stevens & Lee, 208 North Third Street, Harrisburg,
Pennsylvania at 10:00 A.M. on that date (the "Closing Date") that is five (5)
business days after the satisfaction of all conditions to closing (other than
satisfaction of conditions to closing that can only be satisfied at closing), or
at such time and date thereafter as the Parties may mutually agree (the
"Effective Time").

                  2.3      Closing Deliveries.

                           (a)      By the Series A Holders. At the Closing,
each Series A Holder shall deliver, or cause to be delivered:

                                    (i)      A share certificate to the Buyer
         for that number of shares of Series A Preferred Stock set forth
         opposite such Series A Holder's name in Section 2.1; and

                                    (ii)     All other documents and items
         required to be delivered by a Series A Holder pursuant to Section 6.3.

                           (b)      By Buyer. At the Closing, Buyer shall
deliver, or cause to be delivered, a wire transfer of immediately available
funds, to the accounts designated in writing by each of the Series A Holders
prior to the Closing Date, the

                                       5

<PAGE>

amount of the purchase price for the Shares being acquired by the Buyer from
such Series A Holder.

                                 ARTICLE III -

                         REPRESENTATIONS AND WARRANTIES

         Each of the Series A Holders represents and warrants, for himself, but
not jointly, that the statements in this Article III are true and correct. The
representations and warranties of the Series A Holders contained in this Article
III and elsewhere in this Agreement or any other document delivered pursuant to
or contemplated by this Agreement, shall not be affected or deemed waived by
reason of the fact that Buyer and/or its representatives knew or should have
known that any such representation or warranty is or might be untrue or
inaccurate in any respect.

                  3.1      Ownership of Series A Preferred Stock. Each Series A
Holder owns beneficially and of record all outstanding shares of Series A
Preferred Stock set forth opposite his name in Section 2.1 hereof. Each Series A
Holder owns the shares of Series A Preferred Stock set forth opposite his name
in Section 2.1 free and clear of any charge, mortgage, pledge, security
interest, restriction, claim, lien, or encumbrance (collectively, "Liens").
Except as set forth on Schedule 2.1 or in the Shareholder Documents, there are
no outstanding voting agreements or proxies, or other commitments or agreements
of any character relating to the Series A Preferred Stock or otherwise
obligating any Series A Holder to transfer, sell, purchase or redeem any shares
of Series A Preferred Stock. Except for options to acquire shares of Class B
Stock under certain circumstances pursuant to Section 7.4 of a Subscription and
Shareholder Agreement dated July 17, 1997 by and among Davis, FHI and the Series
A Holders, none of the Series A Holders have the right to acquire any additional
shares of FHI Capital Stock.

                  3.2      Authority. The Series A Holders have all requisite
power and authority, to enter into this Agreement and to consummate the
transactions contemplated hereby. This Agreement has been duly executed and
delivered by each of the Series A Holders and constitutes a valid and binding
obligation of each of the Series A Holders in accordance with its terms, except
as enforceability may be limited by bankruptcy and other laws affecting the
rights and remedies of creditors generally and general principles of equity.
Except as set forth in the Shareholder Documents or as described on Schedule
3.2, the execution and delivery of this Agreement by the Series A Holder does
not, and the consummation of the transactions contemplated hereby will not,
conflict with, or result in any violation of, or default under (with or without
notice or lapse of time, or both), or give rise to a right of termination,
amendment, cancellation or

                                       6

<PAGE>

acceleration of any obligation or loss of any benefit under (i) any Contract to
which the Series A Holders or any of them is a party or by which any of them is
bound, or (ii) any permit, concession, franchise, license, judgment, order,
decree, statute, law, ordinance, rule or regulation applicable to the Series A
Holders or any of their properties or assets, or to which the Series A Holders
or any of their properties or assets is subject or bound or that give rise to
any Lien. No consent, approval, order or authorization of, or registration,
declaration or filing with, any Governmental Entity is required by or with
respect to the Series A Holders in connection with the execution and delivery of
this Agreement, or the consummation of the transactions contemplated hereby,
except for the approval of the Pennsylvania Department of Insurance.

                  3.3      Representations Complete. No statement, certificate,
instrument or other writing furnished or to be furnished by the Series A Holders
pursuant to this Agreement or any Schedule or Exhibit hereto or any certificate,
instrument or other writing furnished or to be furnished by the Series A Holders
pursuant hereto, contains or will contain at the Effective Time any untrue
statement of a material fact, or omits or will omit at the Effective Time to
state any material fact necessary in order to make the statements contained
herein or therein, in the light of the circumstances under which made, not
misleading.

                                  ARTICLE IV -

                     REPRESENTATIONS AND WARRANTIES OF BUYER

         Buyer hereby represent and warrant to each of the Series A Holders as
follows:

                  4.1      Organization, Standing and Power. Buyer is a
corporation duly organized, validly existing and in good standing under the laws
of the Commonwealth of Pennsylvania. Buyer has the requisite corporate power to
own its properties and to carry on its business as now being conducted and as
proposed to be conducted and is duly qualified to do business and is in good
standing in each jurisdiction where its ownership or leasing of property or the
conduct of its business requires it to be so qualified. Buyer is not in
violation of any of the provisions of its Articles of Incorporation or Bylaws.

                  4.2      Authority. Buyer has all requisite corporate power
and authority to enter into this Agreement and to consummate the transactions
contemplated hereby. The execution and delivery of this Agreement and the
consummation of the transactions contemplated hereby and thereby have been duly
authorized by all necessary corporate action on the part of Buyer. This
Agreement has been duly executed and delivered by Buyer and constitutes the
valid and

                                       7

<PAGE>

binding obligations of Buyer enforceable against Buyer in accordance with its
terms, except as enforceability may be limited by bankruptcy and other laws
affecting the rights and remedies of creditors generally and general principles
of equity. The execution and delivery of this Agreement does not, and will not,
and the consummation of the transactions contemplated hereby will not, conflict
with, or result in any violation of, or default under (with or without notice or
lapse of time, or both), or give rise to a right of termination, amendment,
cancellation or acceleration of any obligation or loss of a benefit under (i)
any provision of the Articles of Incorporation or Bylaws of Buyer, or (ii) any
Contract, permit, concession, franchise, license, judgment, order, decree,
statute, law, ordinance, rule or regulation applicable to Buyer or any of its
properties or assets, or to which Buyer or any of its properties or assets is
subject or bound or that give rise to any Liens. No consent, approval, order or
authorization of, or registration, declaration or filing with, any Governmental
Entity, is required by or with respect to Buyer in connection with the execution
and delivery of this Agreement or the consummation by Buyer of the transactions
contemplated hereby, except for the filing of a Form A with the Pennsylvania
Department of Insurance and the obtaining of approval therefrom.

                  4.3      Litigation. There is no agreement, judgment,
injunction, decree or order against Buyer or any of its Subsidiaries, or, to the
knowledge of Buyer and its Subsidiaries, any of their respective directors or
officers (in their capacities as such) that would prevent, enjoin, alter or
materially delay any of the transactions contemplated by this Agreement, or that
has or could reasonably be expected to have a Material Adverse Effect on the
ability of Buyer to consummate the transactions contemplated by this Agreement.
Neither Buyer nor any of its Affiliates has been advised by a Person that such
Person is contemplating issuing or requesting (or is considering the
appropriateness of issuing or requesting) any such agreement, judgment,
injunction, decree or order.

                  4.4      Broker's and Finders' Fees. Except for a payment
obligation to CIC, Inc. to be paid equally by Buyer and FHI, Buyer has not
incurred, nor will it incur, directly or indirectly, any liability for brokerage
or finders' fees or agents' commissions or investment bankers' fees or any
similar charges in connection with this Agreement or any transaction
contemplated hereby.

                  4.5      Board Approval. The Board of Directors of Buyer has
approved this Agreement.

                  4.6      Financial Capability. Buyer has and shall have, as of
the Effective Time, sufficient funds to consummate the transactions
contemplated by this Agreement.

                                       8

<PAGE>

                  4.7      Representations Complete. No statement, certificate,
instrument or other writing furnished or to be furnished by Buyer pursuant to
this Agreement, or any certificate furnished or to be furnished by Buyer
pursuant to this Agreement, contains or will contain at the Effective Time any
untrue statement of a material fact, or omits or will omit at the Effective Time
to state any material fact necessary in order to make the statements contained
herein or therein, in the light of the circumstances under which made, not
misleading.

                                   ARTICLE V -

                       CONDUCT PRIOR TO THE EFFECTIVE TIME

                  5.1      No Solicitation. The Series A Holders and their
agents will not, directly or indirectly, (i) take any action to solicit,
initiate or encourage any Takeover Proposal (as defined herein), or engage in
negotiations with, or disclose any nonpublic information relating to FHI or any
of its Subsidiaries to, or afford access to the properties, books or records of
FHI or any of its Subsidiaries to, any Person that has advised FHI, Davis or the
Series A Holders that it may be considering making, or that has made, a Takeover
Proposal. The Series A Holders will promptly notify Buyer after receipt of any
Takeover Proposal or any notice that any Person is considering making a Takeover
Proposal or any request for nonpublic information relating to FHI or any of its
Subsidiaries or for access to the properties, books or records of FHI or any of
its Subsidiaries by any Person that has advised FHI, Davis or any Series A
Holder that it may be considering making, or that has made, a Takeover Proposal,
and will keep Buyer fully informed of the status and details of any such
Takeover Proposal notice, and shall provide Buyer with a true and complete copy
of such Takeover Proposal notice or any amendment thereto, if in writing, or a
complete written summary thereof, if not in writing. As used herein, "Takeover
Proposal" means any offer or proposal for, or any indication of interest in, a
merger or other business combination involving FHI or any of its Subsidiaries or
the acquisition of 20% or more of the outstanding shares of capital stock of
FHI, or a significant portion of the assets of, FHI or any of its Subsidiaries,
other than the transactions contemplated by this Agreement.

                  5.2      Consents; Cooperation. Each of Buyer and the Series A
Holders shall promptly apply for or otherwise seek, and use its reasonable best
efforts to obtain, all consents and approvals required to be obtained by it or
them for the consummation of the transactions contemplated by this Agreement,
and those required to be obtained by the Buyer from the Pennsylvania Department
of Insurance. The Parties will consult and cooperate with one another, and
consider in good faith the views of one another, in connection with any
analyses, appearances, presentations, memoranda, briefs, arguments, opinions and
proposals

                                       9

<PAGE>

made or submitted by or on behalf of any Party in connection with proceedings
before any Insurance Authority.

                  5.3      Legal Requirements. Each of Buyer and the Series A
Holders shall take all reasonable actions necessary to comply promptly with all
legal requirements that may be imposed on any of them with respect to the
consummation of the transactions contemplated by this Agreement, shall promptly
cooperate with and furnish information to any Party necessary in connection with
any such requirements imposed upon such other Party in connection with the
consummation of such transactions, and shall take all reasonable actions
necessary to obtain (and cooperate with the other Parties in obtaining) any
consent, approval, order or authorization of, or any registration, declaration
or filing with, any Governmental Entity or other Person, required to be obtained
or made in connection with the taking of any action contemplated by this
Agreement.

                  5.4      Best Efforts and Further Assurances. Each of the
Parties shall use reasonable best efforts to effectuate the transactions
contemplated hereby and to fulfill and cause to be fulfilled the conditions to
Closing hereunder. Each Party, at the reasonable request of another Party, shall
execute and deliver such other instruments and do and perform such other acts
and things as may be necessary or desirable for effecting completely the
consummation of the transactions contemplated hereby.

                                  ARTICLE VI -

                                   CONDITIONS

                  6.1      Conditions to Obligations of Each Party. The
respective obligations of each Party to consummate and effect this Agreement and
the transactions contemplated hereby shall be subject to satisfaction at or
prior to the Effective Time of the following conditions, any of which may be
waived, in writing, by agreement of all Parties:

                           (a)      No Injunctions or Restraints; Illegality. No
temporary restraining order, preliminary or permanent injunction or other order
issued by any Governmental Entity or other legal or regulatory restraint or
prohibition preventing the consummation of the transactions contemplated by this
Agreement shall be in effect, nor shall any proceeding brought by a Governmental
Entity seeking any of the foregoing be pending; nor shall there be any action
taken, or any statute, rule, regulation or order enacted, entered, enforced or
deemed applicable to the transactions contemplated by this Agreement, that makes
the consummation of the transactions contemplated by this Agreement illegal or
impractical. In the event an

                                       10

<PAGE>

injunction or other order shall have been issued, each Party shall use
commercially reasonable efforts to have such injunction or other order lifted.

                           (b)      Governmental Approvals. The Parties and
their respective Subsidiaries shall have timely filed with and obtained from
each Governmental Entity (including all Insurance Authorities) all filings,
notices, approvals, waivers and consents necessary for consummation of the
transactions contemplated by this Agreement and the transactions contemplated
hereby, including such filings, notices, approvals, waivers and consents as may
be required under applicable state insurance laws.

                           (c)      Davis Stock Purchase Agreement. The
transactions contemplated by the Davis Stock Purchase Agreement shall be
completed prior to, or contemporaneously with, the transactions contemplated by
this Agreement.

                  6.2      Additional Conditions to Obligations of the Series A
Holders. The obligations of the Series A Holders to consummate and effect this
Agreement and the transactions contemplated hereby shall be subject to the
satisfaction at or prior to the Effective Time of the following conditions, any
of which may be waived, in writing, by the Series A Holders.

                           (a)      Representations, Warranties and Covenants.
(i) The representations and warranties of Buyer in this Agreement shall be true
and correct in all material respects (except for such representations and
warranties that are qualified by their terms by a reference to materiality,
which representations and warranties as so qualified shall be true in all
respects) on and as of the date hereof and the Effective Time as though such
representations and warranties were made on and as of such times, and (ii) Buyer
shall have performed and complied in all material respects with all covenants,
obligations and conditions of this Agreement required to be performed and
complied with by Buyer as of the Effective Time.

                           (b)      Certificate of Buyer. The Series A Holders
shall have received a certificate executed on behalf of Buyer by its President
certifying that the condition set forth in Section 6.2(a) shall have been
fulfilled.

                  6.3      Additional Conditions to the Obligations of Buyer.
The obligations of Buyer to consummate and effect this Agreement and the
transactions contemplated hereby shall be subject to the satisfaction at or
prior to the Effective Time of the following conditions, any of which may be
waived, in writing, by Buyer:

                           (a)      Representations, Warranties and Covenants.
(i) The representations and warranties of the Series A Holders in this Agreement
shall be

                                       11

<PAGE>

true and correct in all material respects (except for such representations and
warranties that are qualified by their terms by a reference to materiality,
which representations and warranties as so qualified shall be true in all
respects) on and as of the date hereof and the Effective Time as though such
representations and warranties were made on and as of such times, and (ii) the
Series A Holders shall have performed and complied in all material respects with
all covenants, obligations and conditions of this Agreement required to be
performed and complied with by them as of the Effective Time.

                           (b)      Third Party Consents. FHI shall have
obtained, and Buyer shall have been furnished with evidence reasonably
satisfactory to it, of the consent or approval of those Persons whose consent or
approval shall be required in connection with the transactions contemplated by
this Agreement under any material Contract of FHI or any of its Subsidiaries or
otherwise, except where failure to obtain such consent would not have a Material
Adverse Effect on FHI.

                           (c)      Injunctions or Restraints on Conduct of
Business. No temporary restraining order, preliminary or permanent injunction or
other order issued by any Governmental Entity or other legal or regulatory
restraint provision limiting or restricting Buyer's conduct or operation of the
business of FHI and its Subsidiaries following the transactions contemplated by
this Agreement shall be in effect, nor shall any proceeding brought by any
Governmental Entity seeking the foregoing be pending or threatened in writing.

                           (d)      No Material Adverse Changes. There shall not
have occurred any event that could cause a Material Adverse Effect on FHI.

                           (e)      Consent and Waiver of American Reinsurance
Company. American Reinsurance Company, as the holder of the Series B Preferred
Stock, shall have consented in writing to the transactions contemplated hereby.

                           (f)      Certificate of Incorporation. All of the
shareholders of FHI shall have consented to the adoption by FHI of the Third
Amended and Restated Certificate of Incorporation attached hereto as Exhibit A.

                                 ARTICLE VII -

                        TERMINATION, AMENDMENT AND WAIVER

                  7.1      Termination. At any time prior to the Effective Time
this Agreement may be terminated:

                           (a)      by mutual consent of Buyer and all of the
Series A Holders;

                                       12

<PAGE>

                           (b)      by Buyer or the Series A Holders, if,
without fault of the terminating Party, the Closing shall not have occurred on
or before September 30, 2001 (provided a later date may be agreed upon in
writing by the Parties, and provided further that the right to terminate this
Agreement under this Section 7.1(b) shall not be available to any Party whose
action or failure to act has been the cause of or resulted in the failure of the
transactions contemplated by this Agreement to occur on or before such date and
such action or failure to act constitutes a breach of this Agreement);

                           (c)      by Buyer, if it has terminated the Davis
Stock Purchase Agreement in accordance with its terms or if any of the Series A
Holders shall materially breach any of their representations, warranties or
obligations hereunder and such breach shall not have been cured within fifteen
(15) business days following receipt by the Series A Holders of written notice
of such breach, or if such breach cannot be cured by the Series A Holders within
such time period but can be cured by the Series A Holders prior to the Effective
Time and the Series A Holders has not commenced actions reasonably necessary (in
the opinion of Buyer) to cure such breach;.

                           (d)      by the Series A Holders, if Buyer shall
materially breach any of its representations, warranties or obligations
hereunder and such breach shall not have been cured within fifteen (15) business
days following receipt by Buyer of written notice of such breach, or if such
breach cannot be cured by Buyer within such time period but can be cured by
Buyer prior to the Effective Time and Buyer has not commenced actions reasonably
necessary (in the opinion of FHI) to cure such breach;

                           (e)      by Buyer if a Takeover Proposal shall have
occurred and FHI's Board of Directors does not within ten (10) business days of
such occurrence (i) reconfirm its approval of this Agreement and the
transactions contemplated hereby, and (ii) reject such Takeover Proposal;

                           (f)      by any Party if any permanent injunction or
other order of a Governmental Entity preventing the consummation of the
transactions contemplated by this Agreement shall have become final and
non-appealable.

                  7.2      Effect of Termination. In the event of termination of
this Agreement as provided in Section 7.1, this Agreement shall forthwith become
void and there shall be no liability or obligation on the part of the Series A
Holders or Buyer or its officers, directors, shareholders or Affiliates, except
to the extent that such termination results from the breach by a Party of any of
its representations, warranties or covenants in this Agreement; provided that
the provisions of Section 7.3, Article VIII, Article IX, and this Section 7.2
shall remain in full force and

                                       13

<PAGE>

effect and survive any termination of this Agreement; provided further, that
notwithstanding anything to the contrary contained in this Agreement, if this
Agreement is terminated by a Party because of the breach of this Agreement by
another Party or because one or more of the conditions to the terminating
Party's obligations under this Agreement is not satisfied as a result of another
Party's failure to comply with its obligations hereunder, the terminating
Party's right to pursue all legal remedies shall survive such termination
unimpaired.

                  7.3      Expenses and Termination Fees. Whether or not the
transactions contemplated by this Agreement is consummated, all costs and
expenses incurred in connection with this Agreement and the transactions
contemplated hereby (including the fees and expenses of its advisers,
accountants and legal counsel) shall be paid by the Party incurring such
expense.

                  7.4      Amendment. The Parties may amend this Agreement at
any time by execution of an instrument in writing signed on behalf of each of
the Parties.

                  7.5      Extension; Waiver. At any time prior to the Effective
Time any Party may, to the extent legally allowed, (i) extend the time for the
performance of any of the obligations or other acts of the other Parties, (ii)
waive any inaccuracies in the representations and warranties made to such Party
contained herein or in any document delivered pursuant hereto, and (iii) waive
compliance with any of the agreements or conditions for the benefit of such
Party contained herein. Any agreement on the part of a Party to any such
extension or waiver shall be valid only if set forth in an instrument in writing
signed on behalf of such Party.

                                 ARTICLE VIII -

                                 INDEMNIFICATION

                  8.1      Indemnification By Series A Holders. Subject to the
terms and conditions of this Section 8.1, which shall become effective upon
Closing, each Series A Holders shall indemnify, defend and hold harmless Buyer,
from, against and with respect to any claim, liability, obligation, loss,
damage, deficiency, assessment, encumbrance, judgment, cost, expense (including,
without limitation, attorney fees and costs and expenses incurred in
investigating, preparing, defending against or prosecuting any litigation or
claim, action, suit, proceeding or demand), of any kind or character, arising
out of or in any manner incident, relating or attributable to (i) any inaccuracy
in any representation or any breach or failure of any warranty, covenant or
agreement of FHI, Davis or the Series A Holders whether set forth in this
Agreement, the Davis Stock Purchase Agreement or the Schedules attached hereto
or thereto, or in any certificate, instrument of

                                       14

<PAGE>

transfer or other document or agreement executed by the Series A Holders in
connection with this Agreement or otherwise made or given in connection with
this Agreement, or (ii) any failure by FHI, Davis or the Series A Holders to
perform or observe, or to have performed or observed, in full any covenant,
agreement or condition to be performed or observed by FHI, Davis or the Series A
Holders under this Agreement or the Davis Stock Purchase Agreement or under any
certificates or other documents or agreements executed by the Series A Holders
in connection with this Agreement. The matters specified in clauses (i) and (ii)
above are hereinafter referred to as "Indemnifiable Claims".

                  8.2      Indemnification By Buyer. Subject to the terms and
conditions of this Section 8.2, Buyer shall indemnify, defend and hold harmless
the Series A Holders from, against and with respect to any claim, liability,
obligation, loss, damage, deficiency, assessment, encumbrance, judgment, cost,
expense (including, without limitation, attorneys' fees and costs and expenses
incurred in investigating, preparing, defending against or prosecuting any
litigation or claim, action, suit, proceeding or demand), of any kind or
character, arising out of or in any manner incident, relating or attributable to
(i) any inaccuracy in any representation or any breach or failure of any
warranty, covenant or agreement of Buyer set forth in this Agreement or in any
certificate, other document or agreement executed by Buyer in connection with
this Agreement or otherwise made or given in connection with this Agreement, and
(ii) any failure by Buyer to perform or observe, or to have performed or
observed, in full any covenant, agreement or condition to be performed or
observed by Buyer under this Agreement or under any certificate or other
documents or agreement executed by Buyer in connection with this Agreement.

                  8.3      Classification of Breach. Section 8.1 shall be the
exclusive remedy of Buyer against the Series A Holders in regard to any
Indemnifiable Claim. In the event that the Indemnifiable Claim arises from a
misrepresentation or breach of covenant by a Series A Holder under this
Agreement ("Type I Breach"), his liability shall be for his own breach only, but
shall be for the full amount of the Indemnifiable Claim arising from his breach
and without any limitation on the time in which the notice of the claim must be
given to him by the Buyer. In the event that the Indemnifiable Claim arises from
a misrepresentation or breach of covenant by Davis or FHI under or in connection
with the Davis Stock Purchase Agreement (Type II Breach "), then the liability
of the Series A Holders shall be joint and several, but subject to all of the
limitations set forth in the remaining Sections of this Article VIII.

                                       15

<PAGE>

                  8.4      Limitation on Indemnification Obligation - Type II
Breach. Series A Holders shall have no obligation with respect to any
Indemnifiable Claim arising from a Type II Breach to the extent:

                           (a)      such claim for indemnity does not exceed
Seventy-Five Thousand Dollars ($75,000) and if all such claims exceed
Seventy-Five Thousand Dollars ($75,000) in the aggregate, the Series A Holders
shall be liable for the full amount in excess of Seventy-Five Thousand Dollars
($75,000), subject to the other limitations set forth in this Article VIII;

                           (b)      such claim for indemnity exceeds, or all
such claims for indemnity (inclusive of such claim) exceed, subject to the other
limitations set forth in this Article VIII, the purchase price paid to such
Series A Holders under this Agreement;

                           (c)      the loss, event, liability or matter giving
rise thereto is covered by insurance or reinsurance proceeds or other salvage
reasonably recoverable or actually received by Buyer or FHI on account of the
event that gave rise to the claim;

                           (d)      the event, liability or matter giving rise
thereto provides the Buyer or FHI with any tax benefit; or

                           (e)      the claim is for other than direct
compensatory damages, unless the claim arises from a third party asserting
another form of damages.

                  8.5      Time Limits for Claims against the Series A Holders
- Type II Breach. The Series A Holders shall have no obligation with respect to
any Indemnifiable Claim arising from a Type II Breach unless Buyer provides
written notice to the Series A Holders within the later of:

                           (a)      One year after the Closing Date; or

                           (b)      if the basis for such claim arises from a
breach of any representation or warranty or covenant relating to "Taxes" (as
defined in the Davis Stock Purchase Agreement), in which event the claim may be
asserted any time within the applicable statute of limitations.

                  8.6      Additional Limitation of Indemnification Obligation
of Series A Holders - Type II Breach. In the event that the Series A Holders
shall become obligated to provide indemnification under Section 8.1 in regard to
a Type II Breach, the liability of each Series A Holder shall not exceed the
product of (i) the amount of any such liability as determined after application
of the limitations set forth in Section 8.4, (ii) 0.145, and (iii) a fraction
the numerator of

                                       16

<PAGE>

which is the number of shares of Series A Preferred Stock owned by the Series A
Holder on the date hereof and the denominator of which is 10,000.

                                  ARTICLE IX -

                               GENERAL PROVISIONS

                  9.1      Survival Past Effective Time. The representations,
warranties, covenants and agreements set forth in this Agreement shall survive
the Effective Time, except as provided in Section 8.5.

                  9.2      Notices. All notices and other communications
hereunder shall be in writing and shall be deemed given if delivered personally
or by commercial delivery service, or mailed by registered or certified mail
(return receipt requested) or sent via facsimile (with confirmation of receipt)
to the parties at the following address (or at such other address for a party as
shall be specified by like notice):

         if to Buyer to:

                  Mercer Mutual Insurance Company
                  Route 31 North
                  Pennington, New Jersey
                  Attention: Andrew R. Speaker,
                  President and Chief
                  Executive Officer
                  Facsimile No.: 609-737-8719
                  Telephone No.: 609-737-0426

                  with a copy to:

                  Stevens & Lee
                  1275 Drummers Lane
                  P. O. Box 236
                  Wayne, PA 19087-0236
                  Attention: Jeffrey P. Waldron
                  Facsimile No.: 610-687-1384
                  Telephone No.: 610-293-4961

                  to the Series A Holders, to their respective addresses shown
on Schedule 9.2, with copies as shown on that Schedule and a copy to:

                                       17

<PAGE>

                  Franklin Holding Company, Inc.
                  214 East Church Street
                  Lock Haven, Pennsylvania 17745
                  Facsimile No. 717-570-6655
                  Telephone No. 717-570-3234

                  9.3      Counterparts. This Agreement may be executed in one
or more counterparts, all of which shall be considered one and the same
agreement and shall become effective when one or more counterparts have been
signed by each of the Parties and delivered to the other Parties, it being
understood that all Parties need not sign the same counterpart.

                  9.4      Entire Agreement; Nonassignability; Parties in
Interest. This Agreement and the documents and instruments and other agreements
specifically referred to herein or delivered pursuant hereto, including the
Exhibits, and Schedules (a) constitute the entire agreement among the Parties
with respect to the subject matter hereof and supersede all prior agreements
and understandings, both written and oral, among the Parties with respect to
the subject matter hereof, and shall survive any termination of this Agreement
or the Closing, in accordance with its terms; (b) are not intended to confer
upon any other Person any rights or remedies hereunder; and (c) shall not be
assigned by operation of law or otherwise, except that Buyer may assign its
rights under this Agreement to any of its Subsidiaries, provided that if such
assignee Subsidiary fails to perform any obligation hereunder, Buyer shall
remain liable for full performance thereof.

                  9.5      Severability. In the event any provision of this
Agreement or the application thereof becomes or is declared by a court of
competent jurisdiction to be illegal, void or unenforceable, the remainder of
this Agreement will continue in full force and effect and the application of
such provision to other Persons or circumstances will be interpreted so as
reasonably to effect the intent of the Parties. The Parties further agree to
replace such void or unenforceable provision of this Agreement with a valid and
enforceable provision that will achieve, to the extent possible, the economic,
business and other purposes of such void or unenforceable provision.

                  9.6      Remedies Cumulative. Except as otherwise provided
herein, any and all remedies herein expressly conferred upon a Party will be
deemed cumulative with and not exclusive of any other remedy conferred hereby,
or by law or equity upon such Party, and the exercise by a Party of any one
remedy will not preclude the exercise of any other remedy.

                                       18

<PAGE>

                  9.7      Governing Law. This Agreement shall be governed by
and construed in accordance with the laws of the Commonwealth of Pennsylvania.

                  9.8      Rules of Construction. The Parties have been
represented by counsel during the negotiation, preparation and execution of this
Agreement and, therefore, waive the application of any law, regulation, holding
or rule of construction providing that ambiguities in an agreement or other
document will be construed against the Party drafting such agreement or
document.

         IN WITNESS WHEREOF, Buyer and the Series A Holders have caused this
Agreement to be executed and delivered as of the date first written above.

                                          MERCER MUTUAL INSURANCE
                                          COMPANY

                                          By: /s/ Andrew R. Speaker
                                             _______________________________
                                            Name:  Andrew R. Speaker
                                            Title: President and Chief Executive
                                                   Officer

                                       19

<PAGE>

                                            /s/ Anthony Robert Scatena
                                            __________________________________
                                            Anthony Robert Scatena

                                            /s/ Raymond Edward Nestlerode, Sr.
                                            __________________________________
                                            Raymond Edward Nestlerode, Sr.

                                            /s/ Raymond Edward Nestlerode, Jr.
                                            __________________________________
                                            Raymond Edward Nestlerode, Jr.

                                            /s/ Joseph Russell Nestlerode, Sr.
                                            __________________________________
                                            Joseph Russell Nestlerode, Sr.

                                            /s/ William J. Edwards
                                            __________________________________
                                            William J. Edwards

                                            /s/ Michael Peter Nestarick
                                            __________________________________
                                            Michael Peter Nestarick

                                       20

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00051-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00051-of-00352.parquet"}]]